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ABSTRACT 
 
  
 The goal of this MQP was to identify and characterize differentially expressed 
genes associated with Listeria monocytogenes infection in two strains of mice, 
BALB/cbyj (Listeria sensitive) and C57BL/6ByJ (Listeria resistant).  We identified 
several genes both upregulated and deregulated by the host during infection, and mapped 
one gene’s chromosomal location (though inconclusively) to gain a more complete 
understanding of the biochemical processes involved in the innate immune response.   
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BACKGROUND 
Sources of Listeria monocytogenes  
 Listeria monocytogenes populations are predominately localized throughout water 
and soil.  These bacteria are also found in the gastrointestinal tracts of animals, and may 
be present in up to five percent of healthy adults (Wing and Gregory, 2002).  Listeria has 
been known to be a common source of animal illness since 1911; however, it was not 
until 1929 when the first case of Listeria was detected in humans.  In the 1980s, Listeria 
was also demonstrated to be present in a variety of foods (Fox, 1998).   
L. monocytogenes food contamination begins at the farm and multiplies during its 
time at the slaughterhouse, processing plant, retail store, and home kitchen (Fox, 1998).  
This bacterium can be found in most types of food including:  processed meat, fresh meat 
and fish, raw vegetables such as lettuce and cabbage, apple cider, and dairy products such 
as soft cheeses (Wing and Gregory, 2002).  Listeria is known to be especially well-suited 
for multiplication in processed chicken products (Fox, 1998), along with being frequently 
found in ready-to-eat foods such as hot dogs and cold cuts (Wallace, 2004).  
Contamination of ready-to-eat foods occurs when the finished food product is cross-
contaminated with at least one of the many contaminated areas at a food processing plant 
(Nightingale et al, 2004).   
Nightingale et al (2004) conducted a study that examined the transmission and 
ecology of Listeria monocytogenes on farms.  The study determined that farms are a 
reservoir for human listeriosis cases.  Farms with small ruminants (sheep and goats) and 
farms with large ruminants (cattle) were both considered in their research.  Case farms 
were farms that had experienced a recent case of listeriosis, and control farms were 
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classified as having no known listeriosis cases.  Small ruminant control farms were on 
average only 5.9% Listeria positive, while case farms were 32.9% positive.  The amount 
of L. monocytogenes present within each group of large ruminant farms only varied 
between 20.2% and 24.4%, respectively.  This difference in percentage between small 
and large ruminant farms indicates that Listeria can vary in its epidemiology and 
transmission.  The difference in large ruminant control farms compared to small ruminant 
control farms demonstrates that cattle are important factors in the amplification and 
dispersal of Listeria on the farm (Nightingale et al, 2004). 
The study by Nightingale et al also revealed that Listeria ribotypes taken from 
clinical cases and fecal samples were more prevalent in the environment than in feed 
samples.  This signified that infected animals are probably contributing to the spread of 
Listeria on farms.  The correspondence between the type of Listeria in human listeriosis 
cases and the type of Listeria found on cattle farms was high.  This finding reveals that 
cattle farms are a major source of human listeriosis cases (Nightingale et al, 2004). 
The source of infection for animals was found to be silage feeding.  Nightingale 
and colleagues discovered that silage that was not properly fermented, and contamination 
by soil and crops allowed Listeria to reproduce to substantial numbers.  Once the animals 
ingest the contaminated feed, Listeria is able to amplify within the gastrointestinal tract 
of the animal. The bacteria can then multiply on the ground, which is a result of fecal 
waste from infected animals (Nightingale et al, 2004). 
The centralized food processing system that is now common to the food industry 
has contributed to a recent surge in the cases of Listeria monocytogenes infections.  The 
Food and Drug Administration, along with the food industry, have been trying to reduce 
 9 
this problem with little luck (Wing and Gregory, 2002).  L. monocytogenes is one of the 
four major pathogens present in the food industry that causes serious health problems for 
humans.  The other three pathogens, Campylobacter, Salmonella, and E. coli, all had 
significant decreases in induced infections between 1996 and 2003.  However, the rate of 
Listeria infections did not have a comparable decrease (Wallace, 2004). The American 
Meat Institute found Listeria in one-third of the cultures they collected from the floors 
and drains of meat-processing plants.  They also found the bacterium in more than one-
fifth of the samples taken from cleaning agents, wash areas, sausage peelers, and food 
contact surfaces (Fox, 1998).  The USDA published a study in 1996 which revealed that 
Listeria monocytogenes were found in 11.7 percent of the ground beef samples taken at 
food processing plants (Schlosser, 2002).   
Once the bacteria leave the farm and enter the food processing system, many 
preventative measures are difficult to undertake.  The bacterium can multiply at the low 
refrigeration temperatures of one to forty-five degrees Celsius.  L. monocytogenes are 
also able to replicate at high salt concentrations, which makes the bacteria a problem for 
foods preserved in brine (Wing and Gregory, 2002).  Listeria can survive significant 
thermal shock, which is why the bacteria are not often killed by warming ready-to-eat 
foods (Wallace, 2004). 
 
Listeria Outbreaks 
Although food is now known to be the major cause of listeriosis outbreaks, this 
was not always the case.  It was not until 1981 that Listeria in food was even pinpointed 
as a cause of human infections.  This instance occurred in Canada and resulted in forty-
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one illnesses, with a death rate of twenty-seven percent.  The source of the outbreak was 
cabbage, which had been grown in a field that used manure from infected sheep.  Other 
outbreaks, such as ones in Massachusetts and Los Angeles, also had mortality rates that 
were around thirty percent (Wing and Gregory, 2002).   
One of the most recent major outbreaks of listeriosis occurred between July 1st 
and November 30th of 2002.  The outbreak caused infection in one hundred eighty-eight 
people, resulting in death in some cases.  During the time of the outbreak, Listeriosis 
patients were identified in nine different East Coast and Mid-West states.  Fifty-four of 
the cases were found to be of the same strain.  A study done by the Centers for Disease 
Control (CDC) pinpointed the Wampler Foods plant in Franconia, Pennsylvania, and the 
Jack Labersky Poultry Company in Camden, New Jersey as the source of the Listeria 
contamination.  The companies recalled 27 million and 4.2 million pounds of meat, 
respectively (Wallace, 2004). 
 
Course of Listeria monocytogenes Infection: From Bacterial Ingestion to Intestinal 
Epithelial Invasion and Penetration 
 Listeria can enter the body in a couple of ways.  The most common route of 
infection is through the ingestion of contaminated food; however, infection through the 
skin is also possible.  Cases which involve ingestion of bacteria lead to an invasion via 
the gastrointestinal tract of the host.  The second pathway of infection normally occurs by 
human contact with an infected animal (Drevets et al, 2004).  The first documented cases 
of Listeria infection by contact were by veterinarians who became infected via surface 
contact after they delivered infected lambs (Fox, 1998).  Although this mode of infection 
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was the first to be documented, they presently are a relatively rare occurrence (Drevets et 
al, 2004).   
 Once Listeria enters the body, it employs various methods to overcome the host’s 
cellular defenses (Thompson et al, 1998).  The first line of host defense, though 
ineffective against infection by Listeria monocytogenes, is the intestinal epithelium.  
Infection is initiated by the binding of Listeria cell surface molecules such as the 
internalins Inla and Inlb to receptors on the surface of intestinal epithelia.  These 
receptors include E-cadherin for Inla, and Met and gCIqR for Inlb.  It is at this epithelial 
location that the bacteria are then internalized and encounter components of the innate 
immune system (Baldwin et al, 2002).  Figure 1 demonstrates Listeria’s cell entry 
process.   
 
Figure 1:  Listeria Monocytogenes Cell Entry Process (Cossart and Sansonetti, 2004) 
 
Listeria is ingested by macrophages through the process of phagocytosis (Myers 
et al, 2003).  Once the bacterium has entered the cell, it secretes virulence factors that 
have the ability to degrade the phagosome.  The virulence factors Listeriolysin O (LLO, 
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hly) and the phospholipases PlcA and PlcB work together to disrupt the membrane of the 
vacuole of the phagosome, which allows Listeria to escape being broken down (Baldwin 
et al, 2002).   
A study performed by Myers et. al, illustrated mechanisms which denied 
Listeria’s typical mode of escape from vacuoles of non-activated macrophages.  This 
process usually occurs within thirty minutes of infection.  Meyers showed exceptions to 
this escape process which involved macrophages activated with IFN-, LPS, IL-6, and a 
particular antibody against IL-10, which are able to keep and degrade Listeria within the 
vacuoles.  Escape from the vacuole is also repressed by inhibitors of reactive oxygen 
intermediates (ROI) and reactive nitrogen intermediates (RNI) (Myers et al, 2003).  
These two intermediates are known to be activated during infection (Anjalika et al, 
1999).   Myers and colleagues further showed that ROI and RNI worked together to aid 
in a mouse’s resistance to Listeria, and they also assisted the listericidal activity of 
activated macrophages.  The combination of ROI and RNI inhibit Listeria from escaping 
the vacuole.  Bacteria that are unable to escape the vacuole are subsequently digested 
(Myers et al, 2003).   
Listeria’s travel to the cytosol is beneficial not only in that it avoids death, but 
also because the cytosol is rich in nutrients.  It is here that the bacteria draws upon the 
cellular energy reserves for reproduction (Baldwin et al, 2002).  Thus, the cytoplasm is 
the principle habitat for Listeria after infection (Thompson et al, 1998).  Once the 
bacteria are in the cytosol, they employ their actin cytoskeletal machinery through the 
expression of the protein Act-A.  This is done in a polarized fashion in order to create a 
force which allows for the bacteria to navigate through the cytoplasm.  Expression of the 
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actin bundling protein also aids in the bacteria’s ability to become mobile (Baldwin et al, 
2002).  This protein connects actin filaments (See Figure 2), which creates bundles and 
increases the bacteria’s ability to move (Cohen et al, 2000).  The bacteria then spread 
from cell to cell through the use of this form of actin-based motility (Baldwin et al, 
2002).   
 
Figure 2:  Image of Listeria’s Actin Tails (Cossart and Sansonetti, 2004) 
 
The mobile bacteria that eventually reach the cell plasma membrane form an 
extension that is covered in a membrane (Baldwin et al, 2002).  This is done as a result of 
transient signals that occur following the formation of the first ligand-receptor complex 
(Cossart and Sansonetti, 2004).  These protrusions are in turn “eaten” by nearby cells.  
This allows Listeria to spread without exiting the cytoplasm (Baldwin et al, 2002).  Actin 
movement also enables the bacteria to travel through the intestinal epithelium.  Figure 3 
depicts Listeria’s crossing of the intestinal epithelium and summarizes this section of the 
background.  
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Figure 3:  Listeria monocytogenes Crossing the Intestinal Epithelium 
   (Cossart and Sansonetti, 2004) 
 
Course of Listeria monocytogenes Infection:  From the Bloodstream to Bacterial 
Death 
Listeria monocytogenes that are present in the bloodstream travel both 
intracellularly and extracellularly.  More than ninety percent of the blood leukocytes in 
contact with the bacteria in the bloodstream are CD11b+ mononuclear cells.  Many of 
these infected cells were shown by Drevets et al to be part of the Ly-6chigh subset, the 
importance of which is discussed later in this section (Drevets et al, 2004).   
 As with most organisms, once L. monocytogenes enter the bloodstream, the liver 
quickly clears the bacteria by acting as a primary storage location (Gregory et al, 1996).  
Listeria then invades and replicates within both liver and spleen cells (Tsuji et al, 2004).  
As the blood flows through the liver, the bacteria stick to the surface of hepatic cells.  
The adherence of L. monocytogenes is mediated by both liver lectins expressed by 
hepatocytes and NPC, and carbohydrate receptors that are expressed by the bacteria.  In 
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an experiment done by Gregory et al, sixty percent of bacteria inoculated into mice 
intravenously were found in the liver ten minutes after injection (Gregory et al, 1996).  
This subsequently induces an accumulation of mononuclear phagocytes in the liver 
(Stevenson et al, 1980).  At ten minutes following infection, Listeria within the liver was 
shown to be distributed equally between hepatocytes and nonparechymal liver cells, with 
more than seventy-five percent of this Listeria bound extracellularly (Gregory et al, 
1996).   
It was previously believed that macrophages, specifically Kupffer cells, were the 
main defense of  L. monocytogenes infection; however, recent studies have shown that 
neutrophils have a principal role in early defense mechanisms in the liver (Wing and 
Gregory, 2002).  Although a majority of the bacteria in the liver are killed by neutrophils 
(Gregory et al, 1996), Kupffer cells still play an important role in host defense against 
primary and secondary stages of infections (Gregory et al, 2002).  Kupffer cells have a 
surface composition the bacteria in the liver are able to stick to (Wing and Gregory, 
2002).  These cells are required for the efficient clearance of the bacteria from peripheral 
blood.  They also promote the accumulation of neutrophils (Gregory et al, 2002).   
A second study performed by Gregory et al (2002) showed that two hours 
following infection with Listeria, neutrophils travel to Kupffer cells.  This study 
demonstrated that Listeria is found within neutrophils, and that neutrophils are found 
within Kupffer cells.  The interaction between Kupffer cells and neutrophils is promoted 
by complementary adhesion molecules.  The location of neutrophils within Kupffer cells 
may possibly demonstrate that Kupffer cells are responsible for eliminating neutrophils 
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from the liver while the extracellular organisms in the sinusoids are eliminated (Gregory 
et al, 2002). 
Listeria in the liver are killed rapidly; roughly sixty to ninety percent are 
destroyed within six to twelve hours of infection (Wing and Gregory, 2002).  The 
decrease in bacteria between ten minutes and six hours after infection corresponds with a 
seven-fold increase in the percentage of neutrophils in the nonparenchymal cell 
population.  The neutrophils, which quickly travel to the liver following infection, are 
responsible for the death of the hepatic cells that have the bacteria attached to them 
(Gregory et al, 1996).  The neutrophils responsible for this process are CD11b/CD18 
(Mac-1)- and CD54 (ICAM-1)-dependent, and are located at the surface of Kupffer cells 
(Gregory et al, 2002).   
Chemokines are also important in fighting Listeria monocytogenes at this point of 
infection.  These chemical messengers are influential in attracting neutrophils and natural 
killer cells to an area of infection.  Cheomkines are also able to activate macrophages 
(Cohen et al, 2000).   
At six hours post-infection, roughly ninety-three percent of the Listeria in the 
liver are localized within the liver cells (Gregory et al, 1996).  Bacteria that are located 
within these hepatocytes are able to avoid being eliminated by neutrophils and undergo 
replication within the cell (Gregory et al, 1996).  Multiplication begins between forty-
eight and seventy-two hours post-infection, which is when the liver begins to completely 
destroy the bacteria (Wing and Gregory, 2002).  From the cytosol, L. monocytogenes 
enter the major histocompatibility complex (MHC) class I pathway.  This pathway is part 
of antigen processing and presentation (Thompson et al, 1998).  
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As mentioned previously, the bacteria travel via bloodstream to the spleen as well 
as the liver.  An experiment by Carrero et al (2004) demonstrated that lymphocyte 
apoptosis occurs in the white pulp of the spleen on the second day after infection with 
Listeria monocytogenes.  This experiment used mice which showed that apoptosis in this 
region is induced by the virulence factor Listeriolysin O (LLO).  With caspase activation, 
apoptosis was observed within thirty minutes of treatment.  This team also saw hepatic, 
splenic, and hippocampal apoptosis in mice infected with Listeria.  Hepatic lesions were 
detected twenty-four hours after infection with L. monocytogenes.  Lesions in this area 
were degenerated by a reduction in the number of present neutrophils, or by a blockage of 
systemic TNF- or INF-  secreting T-cells possessing neutralizing antibodies.  It was 
also demonstrated that hippocampal lesions corresponded with the amount of bacterial 
invasiveness (Carrero et al, 2004). 
 
The Role of Cytokines in a Listeria Infection 
Cytokines are known to be vitally important in primary host defense mechanisms.  
Examples of these cytokines are interferon- and interleukins-1, -1, -18 and -12 (Wing 
and Gregory, 2002).  Dendritic cells produce the cytokines IL-12 and IL-10.  These 
cytokines are important in determining the number of T cells that will produce interferon-
.  The first cytokine to assist in host defense to Listeria infection is interferon-, which is 
produced by naïve T cells (Brzoza et al, 2004).  This cytokine initiates the production of 
bactericidal elements from macrophages.   Tumor necrosis factor- is an example of what 
can be produced.  This factor has a role in the activation of neutrophils.  The interferon- 
that is produced by cytotoxic T lymphocytes is vital for the elimination of a Listeria 
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monocytogenes infection.  In a study done by Tsuji et al, the enzyme Caspase-1 was 
shown to be important in the activation of IL-18 in regards to innate immunity against 
pathogens like Listeria.  Resistance to Listeria is controlled by cytokines that have been 
secreted by macrophages and lymphocytes (Tsuji et al, 2004).   
 
Specific Immunity in a Listeria Infection 
Three to four days after infection in a healthy individual, Listeria populations 
begin to decrease in the body.  This is a result of specific immunity mechanisms taking 
over the crude cellular defense of innate immunity (Gregory et al, 1996).  Defense at this 
stage relies on the help of CD+ and CD+ T lymphocytes, monocytes, and natural killer 
cells (Gregory et al, 1996).  At later stages of Listeria infection, CD8+ T cells have been 
shown to lyse infected hepatocytes by perforin- and Fas-L/Fas-dependent mechanisms 
(Wing and Gregory, 2002).  These cells also lyse antigen-expressing cells (Thompson et 
al, 1998).  A vigorous T cell response is associated with protective immunity to L. 
monocytogenes (Brzoza et al, 2004). 
 
Listeria Infection of the Brain 
 Besides the liver and spleen, some of the bacteria in the bloodstream travel with 
the help of dendritic cells from mucosal areas to lymph nodes.  Bacteria may also travel 
within leukocytes to the central nervous system (CNS).  Listeria which reach the CNS are 
important in neuroinvasion.  Drevets et al showed an influx of the previously mentioned 
Ly-6chigh monocytes can be found in the brain following a systemic infection (Drevets et 
al, 2004).  Ly6c is a surface glycoprotein that is expressed on CD8 T cells, moncocytes, 
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and macrophages.  It aids in T cell proliferation and IL-2 production (Jaakkola et al, 
2003).  CD11b+ leukocytes that reached the brains were demonstrated to be Ly-6chigh 
monocytes eighty-eight percent of the time (Drevets et al, 2004). 
 
Virulence Factors of Listeria monocytogenes 
 Observations of the virulence factors of Listeria monocytogenes allowed for the 
understanding of important bacterial properties.  An example of an important virulence 
characteristic is how bacteria can attach and move into a cell.  Virulence factors also 
demonstrated how bacteria can escape from a phagolysosome, move around in the host’s 
cytoplasm, and infect nearby cells (Wing and Gregory, 2002). 
 Many virulence factors exist in L. monocytogenes infections.   These include 
LLO, PlcA, and PlcB which stimulate responses in macrophages and endothelial cells 
(Baldwin et al, 2002).  Listeriolysin O (LLO) is a protein produced by Listeria 
monocytogenes (Wing and Gregory, 2002).  This protein is the most critical virulence 
factor for L. monocytogenes (Brzoza et al, 2004).  This factor is part of the cholesterol-
dependent cytolysin family (Carrero et al, 2004).  The hemosylin gene produces LLO.  
The protein LLO also aids in the bacteria’s ability to escape macrophages and enter the 
cytoplasm, and thus allows for the avoidance of elimination (Brzoza et al, 2004). 
 Carrero et al demonstrated a new function for Listeriolysin O.  This lab showed 
that the stimulation of lymphocyte apoptosis with rapid kinetics is the result of caspase-
dependent and caspase-independent pathways. Caspase-dependence was demonstrated by 
Listeriolysin O causing caspase activation and DNA fragmentation.  Caspase-
independence was seen through phophatidylserine (PS) exposure and a loss of 
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mitochondrial membrane potential.  Carrero et al also showed that purified LLO could 
induce apoptosis of in vitro cultured T cells and lymph node lymphocytes at doses that 
had previously been determined to be non-lytic (Carrero et al, 2004).   
Although Listeriolysin O is a virulence factor, it also has a role in the host’s 
ability to develop immunity to the disease.  A monoclonal antibody specific for 
listeriolysin O (LLO) provides protection against listeriosis.  This finding suggests that 
humeral immunity may be significant in host defense (Wing and Gregory, 2002). 
 The virulence factor PlcB has a different role in L. monocytogenes infection.  This 
factor is directly associated with cerebral virulence (Carrero et al, 2004).  When PclB is 
secreted in its inactive form, bacterial membrane damage is avoided, which proves that 
active PclB is critical in the destruction of cellular membranes.  Plcb is important 
following Listeria’s spread to different cells because at this point of infection PlcB 
phospholipase assists in the lysis of secondary phagosomes.  Vázquez-Boland et al 
(2001) reported that PlcB may mediate Listeria’s escape from primary phagosomes, and 
that it collects in vacuoles which contain L. monocytogenes.  The most important role of 
PlcB is its ability to allow Listeria to spread from macrophages to different types of cells, 
including brain tissue (Vázquez-Boland et al, 2001). 
 PlcA is also a virulence factor of Listeria.  This factor is active in acidified 
phagocytic vesicles.  PlcA has a minimal individual role in virulence; however, it works 
with PlcB and Listeriolysin O to optimize the bacteria’s ability to escape from 
phagosomes.  The virulence factor PlcA also optimizes PlcB’s ability to damage 
phagosome membranes (Vázquez-Boland et al, 2001). 
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Results of Listeria monocytogenes Infection 
 The gram-positive bacteria, Listeria monocytogenes, can cause severe to almost 
unnoticeable effects on its hosts (Wing and Gregory, 2002).  Severe cases of Listeriosis 
often result in fatality.  This fact makes Listeria the food-borne disease with the highest 
death rate (Fox, 1998).  Food poisoning caused by Listeria frequently requires 
hospitalization and causes death in almost one out of every five cases (Schlosser, 2002).  
It is estimated that Listeriosis causes illness in twenty-five hundred people a year, and is 
responsible for the death of roughly five hundred people (Wallace, 2004).   
Listeria monocytogenes can cause adverse health effects in all people.  Healthy 
people typically develop gastroenteritis and bacteremia.  However, Listeria causes much 
more severe problems in immunocompromised individuals (Wing and Gregory, 2002).  
This group of people experiences the same problems as healthy people, but they may 
further succumb to a variety of infections affecting the central nervous system (Drevets et 
al, 2004).  They also are at risk of developing the serious ailments of sepsis and 
meningitis (Wing and Gregory, 2002).   
Twenty-five percent of invasive listeriosis cases are found in pregnant women.  
Listeriosis in pregnant women, also known as maternal listeriosis, causes nonspecific 
febrile illness.  A majority of women who have maternal listeriosis complain of fever.  
They may also complain of a flu-like feeling, back pain, and headaches.  Although 
pregnant women infected with listeriosis feel mild symptoms, their pregnancies often 
result in spontaneous abortions, stillbirths, newborn deaths within hours after birth, or 
neonatal sepsis (Wing and Gregory, 2002).  Infants who do survive are likely to have 
brain damage or cerebral palsy (Fox, 1998). 
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As mentioned previously, a small number of human listeriosis cases are caused by 
direct contact with an infected animal.  These cases often do not result in the same 
conditions as when the bacteria are ingested.  Instead, localized cutaneous infections are 
seen (Nightingale et al, 2004). 
 
Listeria monocytogenes Mouse Model 
 The mouse model of Listeria monocytogenes was developed in the 1962 by 
George Mackaness.  This model has been used to study a variety of health issues related 
to the immune system and has been one of the most important models for explaining the 
process of immunity and host defense to infectious disease (Wing and Gregory, 2002).  
The mouse model has also been used to describe the factors which contribute to cell-
mediated immunity and to describe intracellular pathogen infection.  Specifically, this 
model has either explained or helped explain macrophage activation, adoptive transfer of 
T cell-mediated immunity, function of cytokines, roll of CD4+ and CD8+ T cells, and 
many other important topics.  This model was also the first to demonstrate the virulence 
factors that are expressed by Listeria monocytogenes (Wing and Gregory, 2002). 
 
Genetics and Listeria monocytogenes  
Infection of Listeria monocytogenes causes a variety of genetic changes in the 
host.  These changes are a result of differences in gene expression regulation (Cohen et 
al, 2000).  One example of this was demonstrated by Drevets et al.  They found that the 
influx of monocytes following infection coincides with the up-regulation of the 
macrophage chemoattractant protein-1 gene expression (Drevets et al, 2004).  Another 
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important change was reported by Cohen et al.  They demonstrated that listeriosis 
increases the gene transcription of chemokines in the host.  However, in response to this 
increase, the bacteria develop a substantial decrease in transcription of genes that encode 
chemokine receptors.   
The major host response to Listeria monocytogenes is transcriptionally regulated 
by NFB (Baldwin et al, 2002). This transcription factor is important in the regulation of 
a multitude of genes involved in immune response.  An increase in NFB activity in 
macrophages occurs between ten and twenty minutes following infection.  A second 
increase in activity has been seen after Listeria enters the host cytoplasm.  The 
importance of NFB, along with many other important, previously mentioned factors, in 
signal transduction is shown in Figure 4 (Vázquez-Boland et al, 2001). 
 
Figure 4:  Signal Transduction Pathways and Host Cell Responses to Listeria  monocytogenes 
(Vázquez-Boland et al, 2001). 
 
 A past study done by Stevenson et al revealed that resistance to Listeria infection 
was controlled by the gene Lr.  The genetic advantage of this gene was shown between 
twenty-four and forty-eight hours of infection.  The Lr gene is an autosomal, dominant 
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gene.  This genetic trait is shown phenotypically as an early appearance of a radio-
sensitive precursor cell of the mononuclear phagocyte system (Stevenson et al, 1980).   
 Four years after the study by Stevenson was published, Gervais et al demonstrated 
that there is an allelic difference at the major locus Lr-1 resulting in either resistance or 
sensitivity to Listeria infection.  This study also suggested that a gene called Lr-2 
controlled the level of bacteria needed to cause listeriosis in sensitive mice.  This idea 
was postulated based on the observance of varying degrees of susceptibility in sensitive 
mice (Gervais et al, 1984).  The studies by Gervais and Stevenson reveal that 
susceptibility to Listeria infection is regulated by genetics. 
 Genetics has also been used in the recent attempts to use L. monocytogenes as a 
vaccine vector (Thompson et al, 1998).  A study done by Thompson et al found that when 
Listeria monocytogenes was injected into a mouse that had a double mutant of the genes 
dal and dat, a cytotoxic T-lymphocyte response was elicited.  Even more importantly, 
immunity to Listeria was seen (Thompson et al, 1998).  The dal and dat genes are 
responsible for the synthesis of D-Alanine which is responsible for the synthesis of part 
of the cell wall of L. monocytogenes (Thompson et al, 1998).   
 
Recombinant Inbred Mouse Strains 
 Recombinant inbred (RI) mice are derived through repeatedly inbreeding the 
progeny of an inbred cross.  After several generations, offspring subsets of the initial 
cross achieve genetic homogeneity.  These genetically identical mice can then be 
phenotyped and genotyped as part of a standardized set.   
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 Studies typically carried out in isolated experimentally bred populations of 
unknown or incomplete genetic backgrounds render findings difficult to incorporate into 
the growing pool of genomic data.  RI mice have all of the advantages of being 
retrievable and of relational data basing as the unique progeny of an experimental cross 
while maintaining enough statistical power for locating the position of genes on a 
chromosome, i.e. mapping (Chesler et al., 2003).   
 RI mouse sets have allowed significant advances in genetics.  They are able to 
undergo repeated testing without the need for genotyping because of genomic markers 
that are already labeled and stored in available databases.  This advantage in reusability 
allows efficient genetic mapping and allows the dissection of highly variable traits and 
traits requiring multiple control groups (Chesler et al., 2003). 
 Another advantage of a common reference population of mice is that they can 
provide a point of integration between the various genomic studies currently in progress, 
thus allowing the sharing of results.  The relational approach of studying RI strains 
facilitates the study of multiple effects of single genes without a previously known 
hypothesis required.  By repeatedly studying the same panel of mice, previously 
submitted data can be examined in light of technological advances for uses such as 
monitoring specific expression profiles associated with a phenotype.   
 
L. monocytogenes-Susceptible vs. L. monocytogenes-Resistant Mouse Strains 
  Previous studies into the genetic and cellular mechanisms by which L. 
monocytogenes-resistant and susceptible mouse strains differ have directed attention to 
the innate immune system, specifically, in the role of mononuclear phagocytes.  The 
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cellular basis of enhanced resistance to L. monocytogenes is partly dependent upon a 
relatively large pool of macrophages and the prompt mobilization of these cells to sites of 
infection (Stevenson et al, 1980; Inagaki et al, 1996).  Cell lines from susceptible mice 
exhibited a decrease in macrophage population relative to the resistant mouse lines.  
Macrophage responsiveness to chemotactic factors was also reduced in susceptible mice.   
 The Stevenson et al. study also determined that the level of macrophage 
responsiveness, and similarly L. monocytogenes resistance, was directly related to the 
genetic background of the target mouse.  This conclusion was obtained through 
comparing F1, F2 and appropriate backcross mice with resistant and susceptible parental 
strains.  For instance, the (resistant X susceptible)F1 hybrid mice exhibited an 
intermediate level of both macrophage inflammatory response in vivo and chemotactic 
responsiveness in vitro.  The LD50 of L. monocytogenes F1 mice was likewise 
intermediate to both parental types, illustrating genetic control.  In addition, statistical 
analysis was consistent with the hypothesis that the trait of macrophage inflammatory 
response is controlled by a single, dominant gene carried by resistant mice.   The trait of 
resistance to L. monocytogenes is thus under very similar, if not identical, genetic control 
(Stevenson et al, 1980).   
 Another study performed by Liu et al. (2000) on the dendritic cell (DC) line in 
resistant and susceptible mouse strains agreed that the difference in macrophage 
inflammatory responses is critical in determining the disease outcome.  Specifically, they 
argue that the difference is influenced by early production of IL-12 and IL-15 by DC (Liu 
et al, 2000).  A separate study by Gervais et al. similarly found that a defect in the 
phagocyte inflammatory response was the primary reason for the extreme L. 
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monocytogenes sensitivity exhibited in certain mouse strains (Gervais et al, 1984).  Taken 
together, macrophage population, macrophage ability to respond to chemical signals at 
site of infection, and macrophage inflammatory response all contribute towards 
controlling L. monocytogenes in resistant mice. 
Though these and other studies of L. monocytogenes have profiled genetic and 
cellular changes in response to infection in the individual cell lines of varyingly 
susceptible RI mice, researchers have yet to monitor for global transcriptional differences 
(Boyartchuk, 2004).    
 
CXB Recombinant Inbred Strain Set 
 There are thirteen individual Mus musculus strains within the CXB RI set.  
Created through the crossing of L. monocytogenes-susceptible BALB/cByJ and L. 
monocytogenes-resistant C57BL/6ByJ strains, there are a total of 671 recombinations and 
1579 markers associated with this set (Williams et al., 2001).  Although mapping 
precision is limited due to the number of individual strains within the set, CXB is 
sufficient to map expression differences back to the gene itself (Boyartchuk, 2004). 
 
Genetic Mapping 
 RI strains have been used extensively to map the location of a wide range of 
quantitative traits.  They offer compelling advantages for mapping simple and complex 
genetic traits, especially those with modest heritability characteristics (Williams et al., 
2001).  A primary advantage is that loci which segregate in RI sets can often be mapped 
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with impressive precision without the need for genotyping.  For the purposes of this 
MQP, complex trait analysis is unnecessary for the identification of primary differences.   
 
Transcriptomics: Closed Architecture Systems 
 Transcriptomics, the large-scale monitoring of mRNAs transcribed from a cell’s 
genome, includes a variety of experimental approaches through which proper utilization 
has allowed an increased understanding of biological processes (Scheel et al., 2002).  
These differential gene expression analysis tools are classified into two families of 
technologies: closed and open architecture systems.  Due to the aims of this MQP, open 
systems were not applicable and shall not be discussed. 
 An architecture system is deemed ‘closed’ when the genes that determine the 
space of inquiry are finite, in terms of whole genomes, and predetermined by virtue of 
their inclusion by selection.  Closed systems are inherently limited by this finite inclusion 
characteristic.  This limits their effectiveness by the degree to which a genome is known 
(Green et al., 2001).  However, as genome knowledge has steadily increased over the past 
few years, so have the potential applications of closed systems (Scheel et al. 2002). 
 
Microarrays 
The advent of DNA microarray technology has provided important information 
on the biological roles of genes and cellular physiology (Cohen et al., 2000).  
Microarrays have been used successfully by various labs to identify novel gene 
transcripts with regard to pathology, metabolism, and cell growth.  In addition, 
 29 
microarray technology has identified new drug targets and secondary drug target effects 
(Cohen et al., 2000; Derisi et al., 1997; Martone et al., 1998). 
DNA microarrays are designed to act as reproductions of a target organism’s 
genome.  They are constructed through the robotic alignment of polymerase chain 
reaction (PCR) products on a fixed surface.  The Affymetrix genechip is comprised of 
multiple 25 mer oligonucleotides per gene synthesized as probes using photolithography.  
Included with each probe is a complementary oligonucleotide with a single base pair 
mismatch, serving as a negative control (Lockhart et al., 1996).  Though costly, the chips 
provide a good means of statistical normalization, quality control, and reproducibility 
(Scheel et al., 2002; Cohen et al., 2002). 
DNA microarrays are by far the best option for performing fast, high-throughput 
analyses.  Sensitivity and reproducibility will continue to improve as this technology 
continues to advance.  However, even the most perfect transcriptional “screenshot” is 
simply a representation of the complex regulation pathways present in a cell.  New 
methods of translating the wealth of gene expression data in functional meaning are 
necessary to further improve genomic understanding (Scheel et al., 2002). 
 
rt RT-PCR (real-time Reverse Transcriptase Polymerase Chain Reaction) 
 Real-Time Reverse Transcriptase PCR (rt RT-PCR) allows precise and 
reproducible quantitative determination of the number of mRNA transcripts synthesized 
(Leclerc et al., 2002).  Developed in 1996 by Heid and colleagues, RT-PCR measures 
PCR product accumulation through a dual-labeled flourogenic probe.  Unlike other 
quantitative PCR methods, real-time PCR does not require post-PCR sample reactions.  
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This prevents potential PCR product carry-over contamination and allows faster assays.  
In addition to these qualities, RT-PCR has a target molecule determination range of at 
least five orders of magnitude (Heid et al., 1996).   
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PROJECT PURPOSE 
 
 The goal of this MQP is to identify and characterize differentially expressed genes 
associated with Listeria monocytogenes infection of mice.  Determination of these genes 
will aid in the further understanding of molecules which determine the course and 
outcome of infections specifically targeting the innate immune system.    
 To identify primary expression differences, defined as differences which arise as a 
result of genetic heterogeneity at the gene locus itself, we utilized the CXB Recombinant 
Inbred (RI) mouse set.  Comprised of Listeria sensitive BALB/cByJ and Listeria resistant 
C57BL/6ByJ parental mice strains, the set allowed for genome analysis via Affymetrix 
Gene Chip technology both prior to and after infection with Listeria.  Through 
monitoring which genes were differentially regulated, candidate genes were selected 
based upon their known molecular and biological function for further verification through 
RT-PCR.  Once a candidate gene exhibited differential expression through expression 
array analysis and RT-PCR, the gene was mapped to its chromosomal location using the 
thirteen strain CXB RI mouse RNA panel.  We hypothesized that identification of 
primary expression differences will reveal key events determining the development and 
progression of the innate immune response in mice.    
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METHODS 
Background Procedure (performed by Boyartchuk laboratory) 
 The RI mouse strains L. monocytogenes-resistant C57BL6/ByJ (Black6) and L. 
monocytogenes-sensitive BALB/cByJ (BalbC) were raised at the UMASS Medical 
School Mouse Laboratory.  Liver and spleen RNA samples were collected from mature 
mice at T = 0 hr, T = 24 hr, and T = 48 hr post-infection with L. monocytogenes.   The 
RNA samples were processed according to Affymetrix protocol and hybridized to both 
“A” and “B” Affymetrix chips in the 430 set.  The genechips were scanned and processed 
into data files (Microsoft Excel) for processing via Affymetrix GCOS software.  Each 
genechip was normalized by the software for signal variation using 100 probes 
representing a collection of genes experimentally determined to exhibit uniform 
expression under a variety of experimental conditions.     
 
Identification of Black6/BalbC Gene Expression Differences 
Following the scanning of the genechips and initial processing of data files, analysis 
was divided into two major phases: 1) determining genes differentially expressed 
between the Black6 and BalbC mice before (time = 0 hours) and after (time = 24 hours) 
infection with Listeria; 2) determining differentially expressed genes (upregulated or 
deregulated) in either mouse line at T = 24 hr which previously showed comparable 
expression levels at T = 0 hr. 
Initially, we sorted for candidates according to the formula described in the following 
paragraph to find appropriate genes for which we would design primers.  We developed 
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other methods for identifying candidate genes based on more rigid mathematical criteria 
later in our experimental proceedings. 
In our first candidate gene list, T = 0 hr data, genes were sorted according to the 
formula comparing relative signal [(Black61 = Black62) not equal to (BalbC1 = BalbC2)].  
The formula was utilized for each of the two probes within the Black6 and BalbC strain 
set.  This normalization process for each probe created a baseline for logarithmic and 
relative error comparison.  The following criteria were used in conjunction with the 
previously listed formula: 
- absolute log2 difference of signal between same strain samples less than 0.3 
o low change in gene expression between same strains 
- delta p-value greater than 0.35 or less than 0.65 for same strain signal comparison 
o high experimental error verified that any difference in gene change values 
between the same strains was insignificant 
- absolute log2 difference of signal between baseline and two samples from other strain 
more than 1.0 
o minimum of two-fold difference in gene expression levels between Black6 
and BalbC 
- delta p-value less than 0.0005 or greater than 0.9995 for same strain signal 
comparison 
o low experimental error verified significance of gene expression values 
between the two strains 
 
For T = 24 hr data, genes were sorted according to slightly different criteria, though 
the [(Black61 = Black62 = Black63) not equal to (BalbC1 = BalbC2 = BalbC3)] formula 
was still satisfied.  The fold-difference (“fdifference”) function was used to sort the 
genechip signal data.  Fdifference was calculated by averaging the 3 signals from the 
Black6 and BalbC strains, respectively, and then determining the ratio of Black6 to 
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BalbC.  For fdifferences between 0.0 and 1.0, the negative inverse of the fdifference was 
taken.  Thus, a ratio of B to C, where B is larger, results in a positive fdifference; a ratio 
of B to C, where C is larger, results in a negative fdifference .  Fdifference values over 2 
or below -2 with a Student’s t-test (using the log2 of each probe’s signal) value below 
0.05 for at least one strain set was employed to determine statistically differentially 
expressed genes.  Further selection was made to ensure that the gene signal call (either 
Present, “P”; Absent “A”; or Marginal, “M”) for one strain set were either all “Present” 
or all “Absent”.  In the event that one set was labeled “Absent”, the other strain set 
needed all “Present” signal call values.  Genes fitting this signal pattern were selected as 
they represented genes which were “off”, or not transcribed, for one strain, and “on”, or 
transcribed, in the other strain.    
This first phase of analysis created two subsets of statistically significant 
differentially expressed genes.  The first subset encompassed genes differentially 
expressed prior to Listeria infection; the second subset contained differentially expressed 
genes after Listeria infection.  These subsets were used in the second, more complex 
phase of spreadsheet-based analysis.    
In our second phase of genome analysis using the gene chip data at time T = 0 hr and 
T = 24 hr, we sought to identify candidate genes using a combined formula: at T = 0 hr, 
[(Black61 = Black62) equal to (BalbC1 = BalbC2], and at T = 24 hr, [(Black61 = Black62 = 
Black63) not equal to (BalbC1 = BalbC2 = BalbC3)].  Genes which fit this formula were 
not differentially expressed prior to infection with Listeria; however, 24 hours post-
infection there was a significant difference in gene transcript level between the strains. 
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Analysis for this second phase occurred via Microsoft Excel with the T = 0 hr and T 
= 24 hr BalbC normalized gene chip data.  First, a spreadsheet was created using genes 
from the T = 0 hr sheet which were not differentially expressed between the two strain 
signal sets.  We defined “not differentially expressed” as any gene with a fdifference 
value below 2 or greater than -2.0.  Then, genes which fit the T = 24 hr criteria of a 
fdifference above 2 or below -2 with a Student’s t-test below 0.05 were added.  This 
translated to selecting genes from either mouse strain which exhibited statistically 
significant expression levels at least twice that of the other strain.  The genes matching 
the guidelines from both time periods were not differentially expressed at T = 0 hr, but 
were differentially expressed at T = 24 hr. 
 The next step was to remove genes which exhibited signals below the average 
background variation (“noise”).  Signals at or below noise were unreliable indicators of 
expression.  For the T = 24 hr genes, the background noise according to the gene chip, 
was 62.  Thus, we sorted for B and C signal sets which failed to exhibit total average 
signal strength of 60.  Although one signal set average below 60 was acceptable (we 
considered these as non-expression or “absent” signals), two signal sets below 60 meant 
that differential gene expression could not be determined.  This sorting eliminated genes 
which may have passed earlier specifications for differential expression, but were 
unreliable due to their low signal.   
 To ensure that genes were not left behind which met our criteria for expression, 
but failed to meet the sorting rules, we again analyzed the T = 0 hr and T = 24 hr BalbC-
normalized data.  The T = 0 hr genes were sorted to find new, non-differentially 
expressed genes.  New candidate genes had a fdifference above 2 or below -2 with a t-test 
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value above 0.05.  This new criteria included non differentially expressed T = 0 hr genes 
which failed the statistical test for significance.  New T = 24 hr candidate genes were 
selected using guidelines which accepted a higher possibility of error.  This meant sorting 
for genes with a fdifference greater than 2 or less than -2 with a t-test value between 0.05 
and 0.10.  The genes which met both requirements comprised our master candidate gene 
list, further described in the following paragraph. 
As part of the final sorting process, the candidate genes were prioritized for 
further analysis according to a 0 to 9 priority scale (see Results, Table 1).  A “0” rating 
denoted the less accurate probe of a gene with duplicate oligonucleotides (based either on 
a lower t-test value or through its genomic coverage of the gene).  A “1” rating meant that 
the gene was differentially expressed a time 0, the opposite of the desired condition.  A 
“2” meant that either the probe did not correspond to the gene (through genomic 
coverage) or the label assigned to it differed between the T = 0 hr and T = 24 hr sheets.  
A “3” represented any gene which passed the signal qualifications, but was a member of 
the histocompatibility gene group (unrelated to the innate immune system) or part of the 
immunoglobulin heavy chain (igh) family (the large amount of research previously done 
on this family precludes further interest).  A “4” priority described genes that had already 
been selected during Phase I gene chip analysis.  A “5” gene but lacked a name, 
according to the mouse genome database on the University of California Santa Cruz 
website (www.genome.ucsc.edu).  A “6” priority signified a gene which had some sort of 
numerical notation, but still lacked a formal name.  A “7” priority gene was not a member 
of the histocompatibility or igh group, had not been researched, and had a formal name.  
An “8” denoted that the gene had not been detected during the original phase of sorting, 
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but was identified in the second phase as a viable candidate.  Finally, a “9” meant that the 
gene had not yet been researched and was directly related to the innate immune system.   
 
Real-Time Reverse Transcriptase Polymerase Chain Reaction (rt RT-PCR) 
Confirmation of Differentially Expressed Genes 
 To confirm genechip candidate genes, quantitative real-time RT-PCR was 
selectively employed.  Candidate genes and their associated proteins were researched 
using the online PubMed search engine for a connection to the innate immune system.  
We selected 23 genes listed as differentially expressed between the T = 0 HR and T = 24 
hr genechip sets.  The genes were researched for sequence information and corresponding 
primers were developed. 
 Primers were designed using the online “primer3” program, developed by MIT 
(http://frodo.wi.mit.edu/primer3/primer3_code.html).  For our analysis, 150 to 250 bp 
were selected, spanning an intron junction towards the 3’ end of the genomic DNA when 
possible.  Using the program’s weighting ability in sorting primers, emphasis was placed 
on low 3’ end stability to lower the incidence of primer-dimer or mispriming events.  
Also, series of three or more cyotosine or guanosine base pairs were avoided when 
selecting optimal primers, again as a measure to reduce mispriming events.  The left and 
right primer oligonucleotides were ordered through UMASS Medical School. 
 Real-time RT-PCR was performed using the DNA Engine Opticon 2 instrument 
and corresponding Opticon Monitor software, version 2.01.10.  Occasionally, the Applied 
Biosystems Prism 7000 Sequence Detection System was utilized using the ABI Prism 
7000 SDS Software, version 1.0, whenever the Opticon 2 machine was unavailable.  
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RNA was typically diluted to 30ng/L using optical density measurement prior to 
reaction.  However, stock RNA availability resulted in intial concentrations from 
10ng/L to 60ng/L. 
 
Expression Mapping 
 To map the confirmed differentially expressed gene, the publicly available 
MapManager QTX (version 0.30) software package was utilized.  Candidate genes were 
analyzed through rt RT-PCR analysis of the CXB RI mouse RNA.  This included 11 
strains derived from Black6 and BalbC crosses.  As with the rt RT-PCR, all RNA 
samples were diluted to 30ng/L prior to reaction.  The cycle results of the reaction were 
entered into the MapManager QTX program.  MapManager QTX then provided a listing 
of the most probable chromosomal locations of the gene based on known marker data.   
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RESULTS 
 
 
Phase I: Identifying Differentially Expressed Genes at T = 0 hr, T = 24 Hr 
 
 Two phases of analysis were performed to identify candidate genes.  The first 
phase provided practicing gene sorting, researching information from genomic databases, 
and using statistically relevant sorting methods.  Genes differentially expressed between 
the BalbC and Black6 strains were identified at T = 0 hr and T = 24 hr during this phase 
of analysis. 
 
Identification of BalbC/Black6 Gene Expression Differences - Data Manipulation at 
T = 0 hr 
 
 Using the criteria listed in the methods section, we narrowed 22,691 tested 
mRNAs to 213 possible candidate genes.  Each gene (mRNA) was researched using the 
National Center for Biotechnology Information (NCBI) and Stanford University’s Source 
online genomic databases (http://www.ncbi.nlm.nih.gov; http://source.stanford.edu/cgi-
bin/source/sourceSearch).  The relevant information for each gene (molecular function, 
biological process, cellular component, tissue localization, etc) was then used to 
categorize the 213 genes into three tiered categories – high, medium, and low potential 
candidacy based on their known function within the immune system.  Seventeen genes 
were flagged high importance (red) due to their critical function within the immune 
system.  Twenty-eight genes were marked medium importance (yellow) based upon their 
association with the immune system or high localization percentage within immune 
system related organs.  The remaining 168 genes were labeled low importance 
candidates, as they did not have known functional relation to the immune system.  
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This initial analysis, though providing relevant gene and associated protein 
information, was performed before the second phase of analysis (identifying genes 
activated after Listeria infection) was formulated.  Identifying differentially expressed 
genes using the first phase criteria served to familiarize us with Microsoft Excel, 
statistical analysis (p-value), and effective utilization of online genomic databases.  
However, sorting genes based upon their link to the immune system was too vague to 
commit to the next stage of rt RT-PCR analysis.  In addition, our analysis did not require 
genes differentially expressed at T = 0 hr.  Rather, it was necessary to re-sort for non-
differentially expressed genes at this time.  Revised sorting methods developed later in 
the project rendered this table’s importance secondary to our project goal (Appendix A).      
Identification of BalbC/Black6 Gene Expression Differences - Data Manipulation at 
Time = 24 hr. 
 
 The initial sorting of the 45,102 T = 24 hr probes was performed primarily using 
the change in fold expression value (see Methods).  This analysis yielded 1,346 
candidates.  However, the spreadsheet which contained these probes did not include the 
corresponding gene name.   Though the genes were properly sorted, they lacked clear 
identification and thus were unusable.  
To rectify the situation, Professor Victor Boyartchuk provided a pre-sorted T = 24 
hr spreadsheet which narrowed 45,102 probes down to 203 candidate genes.  Genes were 
selected based on a minimum of a two-fold difference in gene expression between strains, 
using a Student T-Test algorithm to determine statistical relevance.  From this list of 
genes, eight were selected for further research from the BalbC-normalized data, and five 
genes were chosen from the Black6-normalized data due to their significant data. 
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Phase II: Identifying Innate Immune System-Related Genes 
 The second phase of analysis incorporated the previous gene analysis spreadsheet 
performed by the Boyartchuk laboratory with our own sorting products.  Our goal was to 
identify genes differentially expressed by either mouse line 24 hours after infection with 
Listeria which previously did not show differential expression at T = 0 hr. 
 
Identification of BalbC/Black6 Gene Expression Differences – No Differential 
Expression at T = 0 hr, Differential Expression at T = 24 hr 
 The second phase of analysis yielded genes non-differentially expressed at T = 0 
hr and differentially expressed at T = 24 hr.  Following the gene expression criteria 
described in the Methods section, we limited the list to 262 candidate genes (Table 1).  
A “0” to “9” label concerning the gene’s relevance to the project was used to select 
candidate genes for rt RT-PCR analysis.  The Methods section provides a detailed 
explanation of the prioritization scale. 
 
Priority ID (T = 0 HR) 
B sig 
ave 
C sig 
ave f-diff ttest Gene ID (T = 24 HR) 
B sig 
ave 
C sig 
ave f-diff ttest 
9 1425958_at 122.15 169.30 -1.39 0.03 Il1f9 1425958_at 137.63 293.07 -2.17 0.03 
9 1417546_at 342.50 266.70 1.28 0.13 Il2rb 1417546_at 231.13 108.40 2.13 0.00 
9 1421034_a_at 301.85 247.30 1.22 0.07 Il4ra 1421034_a_at 266.00 125.00 2.16 0.02 
9 1420692_at 42.55 49.90 -1.17 0.03 Il2ra 1420692_at 63.47 26.17 2.41 0.00 
9 1450488_at 144.55 185.15 -1.28 0.06 Ccl24 1450488_at 589.30 203.10 2.95 0.01 
8 1417976_at 160.30 269.45 -1.68 0.05 Ada 1417976_at 88.30 196.90 -2.16 0.05 
8 1418184_at 165.90 322.25 -1.94 0.04 2610019I03Rik 1418184_at 68.70 136.10 -2.07 0.07 
8 1420183_at 147.80 128.65 1.15 0.07 --- 1420183_at 73.30 438.30 -5.01 0.07 
8 1420431_at 9.45 19.80 -2.10 0.00 Rptn 1420431_at 8.40 80.50 -7.57 0.06 
8 1422454_at 15.45 21.20 -1.37 0.11 Krt1-13 1422454_at 10.30 85.30 -10.12 0.05 
8 1426995_a_at 111.85 106.35 1.05 0.01 Gfer 1426995_a_at 34.40 102.00 -3.25 0.07 
8 1449611_at 264.50 304.65 -1.15 0.04 --- 1449611_at 56.00 123.20 -2.31 0.06 
8 1427146_at 362.90 262.20 1.38 0.15 AI790298 1427146_at 152.13 73.17 2.00 0.08 
8 1417393_a_at 586.80 736.80 -1.26 0.82 1110035L05Rik 1439422_a_at 331.67 53.57 5.19 0.06 
8 1460216_at 266.70 387.15 -1.45 0.11 Acads 1460216_at 93.33 33.83 3.04 0.08 
8 1439398_x_at 257.40 282.10 -1.10 0.04 Nelf 1436958_x_at 1330.30 494.23 2.87 0.06 
8 1419219_at 481.55 194.25 2.48 0.29 Cyp4f18 1419219_at 117.33 47.10 2.64 0.06 
8 1423443_at 196.05 168.65 1.16 0.03 Slc4a8 1423443_at 74.43 31.17 2.63 0.10 
8 1433705_at 160.90 103.95 1.55 0.03 6330415G19Rik 1433705_at 89.40 41.47 2.38 0.12 
8 1427429_at 5.45 5.25 1.04 0.02 Csf2 1427429_at 94.73 42.33 2.33 0.05 
8 1423639_at 93.55 102.65 -1.10 0.01 Hrh2 1423639_at 80.90 39.70 2.13 0.06 
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8 1421304_at 46.90 32.10 1.46 0.02 Klra2 1421304_at 99.57 48.40 2.13 0.05 
8 1432492_a_at 570.40 323.85 1.76 0.71 Haao 1432492_a_at 104.27 54.67 2.04 0.13 
8 1419947_at 453.85 307.45 1.48 0.22 --- 1419947_at 196.83 96.47 2.02 0.06 
7 1418162_at 107.15 165.95 -1.55 0.04 Tlr4 1418162_at 92.00 200.00 -2.18 0.00 
7 1451513_x_at 2316.65 2179.55 1.06 0.07 Serpina1b 1451513_x_at 27.13 1231.77 -50.52 0.01 
7 1422481_at 92.85 76.25 1.22 0.01 Krt2-1 1422481_at 10.87 315.17 -30.38 0.00 
7 1427268_at 15.35 8.10 1.90 0.02 Flg 1427268_at 3.40 65.00 -26.46 0.04 
7 1418735_at 20.65 34.45 -1.67 0.02 Krt2-4 1418735_at 6.23 143.90 -19.25 0.02 
7 1422401_at 37.35 72.00 -1.93 0.12 Sprr3 1422401_at 6.70 104.60 -16.56 0.01 
7 1421587_at 28.45 45.25 -1.59 0.17 Klk27 1421587_at 8.27 77.10 -11.17 0.03 
7 1449959_x_at 28.20 44.60 -1.58 0.00 Sprrl9 1449959_x_at 13.90 167.50 -11.02 0.01 
7 1452166_a_at 67.75 101.55 -1.50 0.01 Krt1-10 1452166_a_at 36.10 304.23 -7.44 0.03 
7 1424936_a_at 127.00 225.70 -1.78 0.03 Dnahc8 1424936_a_at 44.27 198.97 -4.57 0.00 
7 1424108_at 400.30 647.30 -1.62 0.14 Glo1 1424108_at 136.57 609.10 -4.52 0.00 
7 1451789_a_at 85.40 219.10 -2.57 0.11 Ryk 1451789_a_at 25.67 109.47 -4.42 0.01 
7 1416271_at 81.55 93.35 -1.14 0.10 Perp-pending 1416271_at 16.23 63.70 -3.75 0.02 
7 1420677_x_at 85.10 113.15 -1.33 0.18 Sprrl3 1420677_x_at 31.87 105.03 -3.15 0.03 
7 1460197_a_at 122.65 181.30 -1.48 0.01 Tiarp-pending 1460197_a_at 80.27 256.37 -3.13 0.01 
7 1451858_at 124.00 151.00 -1.22 0.01 MrgA2 1451858_at 91.13 245.97 -2.71 0.00 
7 1422707_at 471.20 647.80 -1.37 0.26 Pik3cg 1422707_at 115.60 284.47 -2.45 0.00 
7 1431056_a_at 166.15 261.35 -1.57 0.08 Lpl 1431056_a_at 79.03 192.53 -2.45 0.00 
7 1420372_at 132.60 105.85 1.25 0.05 Sntb2 1420372_at 35.73 81.43 -2.28 0.00 
7 1428988_at 475.40 507.95 -1.07 0.37 Abcc3 1428988_at 63.63 144.07 -2.25 0.01 
7 1420863_at 92.10 100.20 -1.09 0.07 Dctn4 1420863_at 28.30 60.73 -2.18 0.02 
7 1454622_at 302.50 1173.10 -3.88 0.46 C81234 1454622_at 186.17 396.77 -2.17 0.03 
7 1451095_at 656.70 1298.40 -1.98 0.82 Asns 1451095_at 324.63 681.10 -2.13 0.03 
7 1449897_a_at 222.00 433.00 -1.95 0.03 Mtcp1 1449897_a_at 208.30 453.17 -2.13 0.04 
7 1417513_at 375.05 664.75 -1.77 0.14 Evi5 1417513_at 156.87 333.07 -2.10 0.02 
7 1449340_at 73.90 186.10 -2.52 0.17 Sostdc1 1449340_at 38.47 78.93 -2.08 0.02 
7 1423746_at 1444.55 2107.40 -1.46 0.04 Txndc5 1423746_at 535.77 1090.43 -2.01 0.02 
7 1419720_at 336.25 414.00 -1.23 0.13 Gp9 1419720_at 80.20 164.70 -2.01 0.04 
7 1426658_x_at 1120.45 883.00 1.27 0.08 Phgdh 1426658_x_at 505.77 251.37 2.01 0.00 
7 1419331_at 93.30 69.15 1.35 0.02 Cdh17 1419331_at 102.97 51.80 2.02 0.03 
7 1448229_s_at 690.85 315.10 2.19 0.78 Ccnd2 1448229_s_at 492.37 244.70 2.03 0.01 
7 1417261_at 229.55 133.90 1.71 0.06 Mbtd1 1417261_at 99.37 48.43 2.03 0.03 
7 1422864_at 166.50 90.00 1.85 0.05 Runx1 1422864_at 67.13 32.97 2.06 0.02 
7 1422786_at 127.10 194.80 -1.53 0.06 Slc30a1 1422786_at 90.20 43.53 2.09 0.01 
7 1424542_at 842.95 531.40 1.59 0.21 S100a4 1424542_at 570.20 270.13 2.11 0.00 
7 1450903_at 619.35 286.80 2.16 0.94 Rad23b 1450903_at 488.83 231.00 2.11 0.00 
7 1426561_a_at 184.30 243.70 -1.32 0.07 Npnt 1426561_a_at 120.53 57.23 2.12 0.01 
7 1451146_at 320.80 147.00 2.18 0.13 Zfp386 1451146_at 158.70 73.67 2.17 0.01 
7 1460709_a_at 497.85 431.65 1.15 0.36 Bat5 1460709_a_at 679.80 308.97 2.21 0.00 
7 1416951_a_at 743.10 405.20 1.83 0.35 Atp6v1d 1416951_a_at 682.60 305.87 2.25 0.01 
7 1427257_at 31.40 38.80 -1.24 0.08 Cspg2 1427257_at 78.00 34.93 2.27 0.03 
7 1418805_at 45.70 40.45 1.13 0.00 Sct 1418805_at 195.93 83.80 2.32 0.00 
7 1448901_at 299.55 172.85 1.73 0.07 Cpxm1 1448901_at 159.00 69.80 2.33 0.02 
7 1423260_at 293.85 190.70 1.54 0.30 Idb4 1423260_at 74.80 32.07 2.33 0.00 
7 1421817_at 493.45 257.15 1.92 0.45 Gsr 1421817_at 446.03 191.00 2.34 0.00 
7 1450136_at 572.10 314.15 1.82 0.72 Cd38 1450136_at 508.73 216.33 2.37 0.01 
7 1419354_at 309.60 201.40 1.54 0.07 Klf7 1419354_at 67.43 29.33 2.37 0.03 
7 1427318_s_at 102.15 123.90 -1.21 0.04 Fer1l3 1427318_s_at 99.57 41.73 2.39 0.00 
7 1425966_x_at 990.00 580.00 1.71 0.11 Ubc 1425966_x_at 876.90 371.70 2.41 0.02 
7 1427005_at 226.05 230.05 -1.02 0.13 Snk 1427005_at 131.17 55.73 2.41 0.04 
7 1424616_s_at 182.40 89.35 2.04 0.05 Frag1-pending 1424616_s_at 288.40 116.77 2.45 0.00 
7 1448231_at 435.80 390.80 1.12 0.39 Fkbp5 1448231_at 165.03 68.03 2.46 0.01 
7 1455282_x_at 79.65 43.25 1.84 0.01 Alas1 1455282_x_at 88.80 34.53 2.58 0.00 
7 1417095_a_at 47.35 36.55 1.30 0.09 Hsp70-4 1417095_a_at 174.60 69.23 2.61 0.05 
7 1415803_at 107.25 103.00 1.04 0.01 Cx3cl1 1415803_at 90.57 33.40 2.73 0.01 
7 1448395_at 317.95 184.60 1.72 0.13 Sfrp1 1448395_at 196.60 70.87 2.77 0.00 
7 1417420_at 727.65 496.45 1.47 0.38 Ccnd1 1417420_at 644.30 230.80 2.79 0.00 
7 1421836_at 303.85 206.25 1.47 0.08 Mtap7 1421836_at 173.93 62.53 2.79 0.00 
7 1448698_at 990.50 512.65 1.93 0.11 Ccnd1 1448698_at 816.07 278.90 2.92 0.00 
7 1417633_at 550.85 344.00 1.60 0.59 Sod3 1417633_at 347.13 100.20 3.50 0.01 
7 1416627_at 195.20 172.45 1.13 0.08 Spint1 1416627_at 125.57 31.70 3.92 0.00 
7 1430979_a_at 289.70 177.75 1.63 0.06 Prdx2 1430979_a_at 350.60 55.17 6.16 0.00 
7 1431821_a_at 130.10 9.30 13.99 0.37 Eps8l1 1431821_a_at 63.17 7.30 9.55 0.01 
6 1453092_at 32.75 24.90 1.32 0.01 2300002G24Rik 1453092_at 10.70 70.73 -6.20 0.02 
6 1428781_at 69.85 34.95 2.00 0.01 1110014F24Rik 1428781_at 31.97 157.57 -4.53 0.03 
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6 1424415_s_at 52.45 74.85 -1.43 0.02 D330035F22Rik 1424415_s_at 20.33 81.10 -4.02 0.00 
6 1423494_at 110.85 139.90 -1.26 0.05 2310042E22Rik 1423494_at 18.60 67.07 -3.52 0.02 
6 1427998_at 157.90 360.95 -2.29 0.07 1110032E16Rik 1427998_at 83.50 247.20 -2.97 0.00 
6 1426787_at 222.35 411.95 -1.85 0.08 2310047I15Rik 1426787_at 132.13 307.90 -2.34 0.00 
6 1423680_at 376.35 641.95 -1.71 0.11 0710001O03Rik 1423680_at 98.73 207.60 -2.11 0.00 
6 1420339_at 60.95 96.45 -1.58 0.08 0610016J10Rik 1420339_at 36.10 77.40 -2.11 0.03 
6 1417575_at 136.75 239.70 -1.75 0.06 4930586I02Rik 1417575_at 96.57 200.17 -2.10 0.02 
6 1451667_at 81.20 125.35 -1.54 0.02 C530043G21Rik 1451667_at 31.70 66.10 -2.08 0.00 
6 1451313_a_at 238.60 258.40 -1.08 0.07 1110067D22Rik 1451313_a_at 121.20 248.83 -2.06 0.01 
6 1429457_at 162.75 231.75 -1.42 0.02 2310020A21Rik 1429457_at 46.83 95.00 -2.03 0.00 
6 1453677_a_at 360.35 506.85 -1.41 0.43 1810063P04Rik 1453677_a_at 92.27 184.40 -2.01 0.01 
6 1421204_a_at 210.05 132.40 1.59 0.04 2310041H06Rik 1421204_a_at 68.37 34.63 2.01 0.03 
6 1437111_at 159.10 118.25 1.35 0.08 A230108E06 1437111_at 102.77 50.87 2.02 0.00 
6 1439049_at 464.30 224.20 2.07 0.24 2410012M04Rik 1439049_at 185.03 91.07 2.05 0.01 
6 1434617_x_at 35.10 26.45 1.33 0.02 1810073N04Rik 1434617_x_at 106.27 46.77 2.30 0.02 
6 1429076_a_at 1038.95 558.45 1.86 0.12 9130017L10Rik 1429076_a_at 287.57 121.23 2.38 0.00 
6 1417233_at 631.65 419.55 1.51 0.82 2810014D17Rik 1417233_at 317.57 128.83 2.47 0.00 
6 1431314_a_at 280.05 150.35 1.86 0.05 5830417I10Rik 1431314_a_at 102.53 40.87 2.52 0.00 
6 1416713_at 58.65 92.50 -1.58 0.05 2700055K07Rik 1416713_at 71.90 28.60 2.52 0.00 
6 1425360_at 191.05 144.90 1.32 0.04 AI315037 1425360_at 74.67 27.80 2.83 0.05 
6 1417393_a_at 586.80 736.80 -1.26 0.82 1110035L05Rik 1417393_a_at 763.40 204.10 3.47 0.04 
5 1434227_at 21.65 17.00 1.27 0.14 --- 1434227_at 8.67 168.97 -30.42 0.03 
5 1425584_x_at 199.30 285.75 -1.43 0.15 --- 1425584_x_at 62.50 274.50 -4.42 0.00 
5 1426114_at 4779.55 6298.45 -1.32 0.02 --- 1426114_at 1218.80 2611.87 -2.15 0.01 
5 1426200_at 175.80 321.80 -1.83 0.06 --- 1426200_at 142.47 300.30 -2.07 0.03 
5 
AFFX-r2-Bs-phe-
3_at 5230.85 5697.75 -1.09 0.01 --- 
AFFX-r2-Bs-phe-
3_at 36.43 74.27 -2.04 0.03 
5 1426632_at 198.45 224.30 -1.13 0.11 --- 1426632_at 72.03 33.70 2.21 0.05 
5 1424607_a_at 1633.65 961.65 1.70 0.16 --- 1424607_a_at 2379.50 1069.43 2.22 0.00 
5 1424609_a_at 1636.70 917.40 1.78 0.16 --- 1424609_a_at 2467.73 1100.70 2.24 0.00 
5 1427819_at 470.20 315.10 1.49 0.27 --- 1427819_at 150.33 62.80 2.39 0.00 
5 1426633_s_at 206.40 88.35 2.34 0.08 --- 1426633_s_at 81.03 14.47 5.58 0.00 
4 1419697_at 21.90 41.95 -1.92 0.05 Cxcl11 1419697_at 596.83 2167.57 -3.61 0.00 
4 1417112_at 931.40 1040.20 -1.12 0.13 Arl2bp 1417112_at 355.83 100.47 3.55 0.00 
4 1424877_a_at 296.70 4099.35 -13.82 0.06 Alad 1424877_a_at 342.30 1857.93 -5.80 0.02 
4 1417764_at 526.05 1132.20 -2.15 0.47 Ssr1 1417764_at 259.87 536.80 -2.07 0.00 
4 1435885_s_at 241.50 452.35 -1.87 0.09 Itsn 1435885_s_at 42.13 85.83 -2.06 0.03 
4 1425216_at 291.50 211.45 1.38 0.11 Gpr43 1425216_at 504.03 248.83 2.03 0.00 
4 1426471_at 236.15 126.70 1.86 0.09 Zfp52 1426471_at 136.63 57.03 2.39 0.00 
4 1451448_a_at 578.30 180.15 3.21 0.76 1110005A03Rik 1451448_a_at 264.83 110.53 2.40 0.00 
4 1438651_a_at 310.00 412.55 -1.33 0.06 Agtrl1 1438651_a_at 174.33 27.63 6.29 0.00 
4 1417600_at 523.00 267.55 1.95 0.68 Slc15a2 1417600_at 351.37 54.60 6.35 0.00 
4 1451644_a_at 408.25 170.90 2.39 0.14 H2-Q1 1451644_a_at 783.10 102.63 8.07 0.01 
4 1425451_s_at 739.30 155.95 4.74 0.36 Chi3l4 1425451_s_at 438.57 52.30 8.27 0.00 
4 1435330_at 2321.60 230.75 10.06 0.06 AI447904 1435330_at 2708.50 276.43 9.79 0.00 
4 1419764_at 1170.30 142.95 8.19 0.07 Chi3l3 1419764_at 929.90 82.73 11.45 0.00 
4 1421144_at 1914.30 138.40 13.83 0.06 Rpgrip1 1421144_at 963.63 55.63 17.42 0.00 
4 1424857_a_at 1682.80 69.05 24.37 0.08 Trim34 1424857_a_at 1697.57 69.50 24.80 0.00 
4 1437432_a_at 369.55 1.40 263.96 0.14 Trim12 1437432_a_at 569.00 1.93 399.73 0.01 
4 1425294_at 360.10 152.65 2.36 0.13 Blame-pending 1425294_at 881.90 363.07 2.45 0.00 
4 1438716_at 200.20 3.65 54.85 0.07 Trim30 1438716_at 627.37 222.27 2.92 0.03 
3 1422892_s_at 46.60 8498.50 
-
182.37 0.22 H2-Ea 1422892_s_at 59.53 3008.77 -83.01 0.02 
3 1422201_at 1068.00 225.45 4.74 0.14 H2-Ob 1422201_at 204.10 51.80 3.96 0.00 
3 1421653_a_at 2530.80 708.05 3.57 0.05 Igh-VJ558 1421653_a_at 1298.43 226.00 5.72 0.00 
3 1425137_a_at 442.65 103.65 4.27 0.23 H2-Q10 1425137_a_at 90.67 12.73 7.84 0.02 
2 1427837_at 781.35 1246.50 -1.60 0.50 Igk-V8 1427837_at 334.93 937.97 -2.72 0.03 
2 1437401_at 824.45 692.35 1.19 0.26 Igf1 1437401_at 119.13 307.70 -2.57 0.00 
2 1452536_s_at 446.30 665.40 -1.49 0.25 Igk-V8 1452536_s_at 139.03 335.30 -2.40 0.01 
2 1455372_at 54.80 97.60 -1.78 0.03 Cpeb3 1455372_at 31.57 72.93 -2.32 0.00 
2 1427856_a_at 57.25 85.30 -1.49 0.01 Igk-V8 1427856_a_at 32.77 72.77 -2.23 0.00 
2 1451091_at 1690.20 2171.30 -1.28 0.03 Txndc5 1451091_at 444.73 930.53 -2.07 0.02 
2 1434045_at 482.65 725.20 -1.50 0.30 Cdkn1b 1434045_at 250.77 514.30 -2.03 0.03 
2 1421835_at 156.60 89.50 1.75 0.04 Mtap7 1421835_at 75.20 37.13 2.01 0.01 
2 1417676_a_at 203.55 155.95 1.31 0.06 Ptpro 1417676_a_at 118.93 58.00 2.04 0.00 
2 1427849_a_at 174.90 79.20 2.21 0.05 Tcrb-V13 1427849_a_at 61.17 26.07 2.36 0.03 
2 1431328_at 129.25 293.15 -2.27 0.05 Ppp1cb 1431328_at 87.90 243.13 -2.77 0.00 
2 1435129_at 1618.60 3645.35 -2.25 0.07 Ptp4a2 1435129_at 725.83 2002.20 -2.76 0.00 
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2 1429859_a_at 448.60 481.30 -1.07 0.22 Arl2bp 1429859_a_at 155.50 30.63 5.07 0.00 
2 1435872_at 541.90 132.70 4.08 0.53 Pim1 1435872_at 834.23 94.67 8.80 0.00 
2 1425385_a_at 1069.75 53.50 20.00 0.39 Igh-1 1425385_a_at 717.77 23.83 30.25 0.00 
2 1425614_x_at 100.30 5454.55 -54.38 0.20 H2-D1 1425614_x_at 26.63 3245.83 
-
182.90 0.01 
2 1448745_s_at 2.70 3.70 -1.37 0.00 --- 1448745_s_at 0.97 152.50 
-
131.31 0.01 
2 1452544_x_at 272.60 7506.10 -27.54 0.44 H2-D1 1452544_x_at 40.57 3561.43 
-
113.62 0.01 
2 1427651_x_at 132.15 5851.85 -44.28 0.28 H2-D1 1427651_x_at 39.73 3326.40 -99.66 0.01 
2 1452677_at 17.05 119.35 -7.00 0.09 1200003F12Rik 1452677_at 12.03 187.87 -20.95 0.04 
2 1452406_x_at 565.80 2250.35 -3.98 0.77 edr 1452406_x_at 151.10 3105.33 -20.72 0.00 
2 1425583_at 36.80 44.65 -1.21 0.02 --- 1425583_at 13.80 71.60 -5.31 0.00 
2 1452535_at 511.05 1461.95 -2.86 0.39 Igk-V8 1452535_at 181.60 784.13 -4.20 0.01 
2 1420350_at 73.50 96.40 -1.31 0.01 Sprrl3 1420350_at 28.70 107.20 -3.51 0.03 
2 1419409_at 107.05 181.80 -1.70 0.04 --- 1419409_at 30.33 99.43 -3.14 0.03 
2 1451678_at 306.05 970.55 -3.17 0.09 Narf-pending 1451678_at 186.13 473.60 -2.59 0.02 
2 1426201_at 252.15 556.80 -2.21 0.07 Igk-V8 1426201_at 146.60 384.17 -2.58 0.02 
2 1425243_at 105.00 531.20 -5.06 0.17 
Langerin-
pending 1425243_at 28.67 70.07 -2.49 0.02 
2 1450354_a_at 22.85 673.10 -29.46 0.17 Ptdss2 1450354_a_at 120.23 279.23 -2.39 0.03 
2 1425738_at 1567.55 4428.40 -2.83 0.07 Igk-V8 1425738_at 654.13 1604.70 -2.37 0.04 
2 1427427_at 80.80 125.65 -1.56 0.04 1700056A21Rik 1427427_at 26.57 61.73 -2.33 0.00 
2 1427518_at 38.10 53.30 -1.40 0.00 LOC234358 1427518_at 28.57 62.90 -2.23 0.01 
2 1425063_at 118.00 166.80 -1.41 0.01 Fcrh1-pending 1425063_at 56.93 121.57 -2.21 0.05 
2 1417169_at 159.45 227.45 -1.43 0.03 B930035K21Rik 1417169_at 29.17 65.10 -2.21 0.01 
2 1437999_x_at 814.25 3777.05 -4.64 0.23 Pigq 1437999_x_at 661.93 1410.43 -2.20 0.04 
2 1450744_at 400.10 881.15 -2.20 0.14 Ell2-pending 1450744_at 364.10 768.00 -2.12 0.01 
2 1423071_x_at 649.35 749.35 -1.15 0.71 --- 1423071_x_at 163.80 345.70 -2.12 0.01 
2 1416963_at 654.85 4011.55 -6.13 0.68 Gdbr1-pending 1416963_at 707.50 1472.13 -2.11 0.02 
2 1426668_at 297.15 498.40 -1.68 0.05 2310024J23Rik 1426668_at 199.80 406.77 -2.05 0.01 
2 1455477_s_at 196.65 618.35 -3.14 0.06 Map17-pending 1455477_s_at 142.97 292.63 -2.04 0.02 
2 1438291_x_at 1230.70 564.05 2.18 0.07 Rpl37 1438291_x_at 646.07 321.20 2.00 0.00 
2 1425947_at 56.05 46.25 1.21 0.03 Ifng 1425947_at 2427.73 1198.80 2.04 0.01 
2 1437142_a_at 377.55 174.60 2.16 0.16 --- 1437142_a_at 182.67 83.47 2.20 0.01 
2 1456663_x_at 213.05 91.60 2.33 0.08 Blp1-pending 1456663_x_at 89.47 38.90 2.31 0.01 
2 1428662_a_at 823.05 657.05 1.25 0.25 Hop-pending 1428662_a_at 363.07 141.17 2.58 0.00 
2 1451776_s_at 234.45 100.65 2.33 0.09 Hop-pending 1451776_s_at 118.93 46.83 2.61 0.02 
2 1433913_at 483.90 167.25 2.89 0.33 Rmp-pending 1433913_at 246.77 84.47 2.93 0.00 
2 1434341_x_at 353.75 160.90 2.20 0.15 --- 1434341_x_at 124.73 44.73 2.95 0.04 
2 1434280_at 333.90 285.70 1.17 0.10 Xbp1 1434280_at 363.43 114.33 3.13 0.01 
2 1437608_x_at 559.60 129.25 4.33 0.67 Ywhaq 1437608_x_at 459.77 127.83 3.45 0.02 
2 1426174_s_at 405.05 105.85 3.83 0.16 AU044919 1426174_s_at 226.77 37.23 6.06 0.00 
2 1431213_a_at 1939.05 233.10 8.32 0.45 --- 1431213_a_at 226.27 33.10 6.30 0.02 
2 1424631_a_at 522.90 110.05 4.75 0.51 AU044919 1424631_a_at 353.97 48.03 7.31 0.00 
2 1456471_x_at 652.75 170.30 3.83 0.84 Phgdh 1456471_x_at 308.07 39.90 7.76 0.00 
2 1455869_at 654.95 77.10 8.49 0.91 --- 1455869_at 138.60 20.73 7.77 0.04 
2 1434340_at 243.40 27.30 8.92 0.09 --- 1434340_at 75.37 8.50 8.89 0.00 
2 1438223_at 50.65 30.00 1.69 0.01 D130040H23Rik 1438223_at 74.07 8.67 9.36 0.01 
2 1454714_x_at 982.05 197.35 4.98 0.37 Phgdh 1454714_x_at 501.57 42.97 11.78 0.00 
1 1417461_at 574.30 2295.95 -4.00 0.75 Cap1 1417461_at 120.23 1561.43 -13.59 0.00 
1 1417462_at 329.40 1863.95 -5.66 0.07 Cap1 1417462_at 86.53 960.80 -11.88 0.01 
1 1418773_at 25.45 328.55 -12.91 0.14 Fads3 1418773_at 47.73 154.20 -3.25 0.00 
1 1418809_at 503.90 247.40 2.04 0.38 Pira1 1418809_at 342.63 942.37 -2.76 0.00 
1 1424171_a_at 222.95 1682.25 -7.55 0.05 Hagh 1424171_a_at 272.07 639.43 -2.35 0.01 
1 1449389_at 290.80 1861.70 -6.40 0.05 Tal1 1449389_at 360.27 817.90 -2.26 0.03 
1 1436945_x_at 214.75 604.85 -2.82 0.08 Stim1 1436945_x_at 109.40 243.97 -2.23 0.00 
1 1416923_a_at 1007.35 3176.35 -3.15 0.10 Bnip3l 1416923_a_at 923.63 2058.87 -2.21 0.01 
1 1419741_at 1078.40 2356.75 -2.19 0.09 Supt16h 1419741_at 513.97 1099.70 -2.15 0.01 
1 1448829_at 309.55 740.75 -2.39 0.06 Smc6l1 1448829_at 112.13 238.90 -2.15 0.01 
1 1426817_at 491.15 3786.50 -7.71 0.34 Mki67 1426817_at 1052.77 2202.23 -2.14 0.04 
1 1448525_a_at 562.90 1458.30 -2.59 0.72 Bnip3l 1448525_a_at 423.10 901.67 -2.13 0.00 
1 1421963_a_at 412.10 1331.85 -3.23 0.15 Cdc25b 1421963_a_at 264.13 559.60 -2.10 0.01 
1 1416468_at 397.85 1604.95 -4.03 0.13 Aldh1a1 1416468_at 452.90 957.27 -2.08 0.03 
1 1422160_at 148.55 327.25 -2.20 0.05 H2-T24 1422160_at 325.63 663.03 -2.03 0.00 
1 1416107_at 463.25 155.55 2.98 0.29 Nsg2 1416107_at 165.43 83.60 2.01 0.03 
1 1451148_at 688.30 235.20 2.93 0.52 Pink1 1451148_at 227.10 112.37 2.02 0.00 
1 1460352_s_at 552.65 157.95 3.50 0.59 Pik3r4 1460352_s_at 203.13 97.50 2.08 0.00 
1 1416946_a_at 440.20 153.90 2.86 0.25 Acaa1 1416946_a_at 155.67 75.53 2.09 0.02 
 45 
1 1416499_a_at 512.35 114.70 4.47 0.40 Dctn6 1416499_a_at 163.50 75.43 2.13 0.03 
1 1418252_at 360.45 176.35 2.04 0.14 Padi2 1418252_at 91.00 42.20 2.14 0.01 
1 1431232_a_at 424.50 167.85 2.53 0.17 Mga 1431232_a_at 249.40 116.50 2.15 0.01 
1 1418885_a_at 865.10 235.60 3.67 0.22 Idh3b 1418885_a_at 288.83 134.27 2.16 0.01 
1 1438462_x_at 458.95 136.30 3.37 0.23 Khdrbs1 1438462_x_at 186.80 85.33 2.16 0.01 
1 1416770_at 785.95 285.45 2.75 0.30 Stk25 1416770_at 258.40 110.07 2.35 0.00 
1 1436846_x_at 634.85 276.15 2.30 0.82 Ywhaq 1436846_x_at 496.83 188.43 2.63 0.00 
1 1452367_at 230.45 86.65 2.66 0.06 Coro2a 1452367_at 229.27 77.00 2.95 0.00 
1 1451969_s_at 698.40 140.85 4.96 0.69 Adprtl3 1451969_s_at 711.33 221.03 3.22 0.00 
1 1453752_at 521.20 215.05 2.42 0.44 Rpl17 1453752_at 258.03 79.20 3.45 0.03 
1 1421550_a_at 734.75 220.45 3.33 0.38 Trim34 1421550_a_at 801.10 221.77 3.63 0.00 
1 1424615_at 262.70 102.65 2.56 0.09 Frag1-pending 1424615_at 380.03 89.00 4.27 0.00 
1 1460187_at 263.35 65.95 3.99 0.10 Sfrp1 1460187_at 320.30 74.30 4.41 0.01 
1 1417470_at 1880.95 298.55 6.30 0.07 Apobec3 1417470_at 1499.70 302.73 4.93 0.00 
1 1419327_at 107.45 813.20 -7.57 0.08 AA415817 1419327_at 24.37 352.67 -15.00 0.00 
1 1431241_at 129.85 285.40 -2.20 0.05 0610041L09Rik 1431241_at 40.63 127.93 -3.14 0.00 
1 1451975_at 343.80 1562.95 -4.55 0.10 2810453I06Rik 1451975_at 448.40 1096.80 -2.42 0.02 
1 1423652_at 456.50 2451.50 -5.37 0.24 1810010A06Rik 1423652_at 528.83 1253.97 -2.39 0.01 
1 1455719_at 1326.00 3402.85 -2.57 0.10 B130022C14Rik 1455719_at 688.40 1636.97 -2.37 0.00 
1 1424584_a_at 495.85 1707.65 -3.44 0.36 4432417N03Rik 1424584_a_at 350.97 788.77 -2.25 0.00 
1 1424888_at 557.20 2726.15 -4.89 0.62 9530046H09Rik 1424888_at 728.37 1607.83 -2.20 0.01 
1 1451609_at 33.75 622.95 -18.46 0.09 1300010A20Rik 1451609_at 100.50 209.37 -2.09 0.02 
1 1416309_at 286.50 1988.00 -6.94 0.07 2610201A12Rik 1416309_at 494.30 1034.87 -2.08 0.04 
1 1438318_x_at 1283.00 553.15 2.32 0.07 1500001L15Rik 1438318_x_at 825.37 395.57 2.07 0.01 
1 1417146_at 414.55 191.25 2.17 0.15 2410018C20Rik 1417146_at 180.87 83.33 2.19 0.01 
1 1452189_at 874.65 330.10 2.65 0.17 9430077D24Rik 1452189_at 582.57 259.90 2.34 0.05 
1 1436212_at 721.80 132.50 5.45 0.49 AI661017 1436212_at 207.17 65.37 3.19 0.00 
1 1452705_at 368.30 50.75 7.26 0.13 AA415817 1452705_at 119.60 31.40 3.92 0.01 
1 1423748_at 399.30 81.75 4.88 0.16 D530020C15Rik 1423748_at 231.63 46.43 5.01 0.00 
1 1423747_a_at 286.50 29.15 9.83 0.07 D530020C15Rik 1423747_a_at 321.53 56.43 5.71 0.00 
1 1419152_at 218.20 42.60 5.12 0.08 2810417H13Rik 1419152_at 170.93 13.17 12.44 0.00 
1 1425917_at 9.90 264.75 -26.74 0.09 --- 1425917_at 20.67 2065.63 
-
251.40 0.04 
1 1425471_x_at 514.60 32.30 15.93 0.41 --- 1425471_x_at 225.97 46.27 4.94 0.00 
1 1425470_at 293.80 5.10 57.61 0.07 --- 1425470_at 170.23 4.87 42.90 0.01 
0 1424109_a_at 924.00 1392.00 -1.51 0.16 Glo1 1424109_a_at 382.83 1333.67 -3.52 0.00 
0 1426388_s_at 86.00 169.55 -1.97 0.02 Ryk 1426388_s_at 29.87 91.63 -3.18 0.03 
0 1425829_a_at 78.20 103.20 -1.32 0.01 Tiarp-pending 1425829_a_at 27.00 81.47 -3.08 0.02 
0 1433966_x_at 299.00 673.80 -2.25 0.47 Asns 1433966_x_at 201.80 436.97 -2.23 0.05 
0 1449840_at 40.85 33.95 1.20 0.04 Sntb2 1449840_at 32.47 67.57 -2.10 0.01 
0 1417419_at 347.90 214.40 1.62 0.23 Ccnd1 1417419_at 327.63 133.53 2.51 0.02 
0 1417634_at 316.40 176.75 1.79 0.10 Sod3 1417634_at 135.77 48.47 2.84 0.01 
0 1418282_x_at 2982.50 2952.45 1.01 0.01 Serpina1b 1418282_x_at 42.13 1350.30 -33.86 0.00 
0 1451240_a_at 188.95 203.10 -1.07 0.02 Glo1 1451240_a_at 119.53 507.03 -4.36 0.01 
Priority Scale Key: 0 to 9 
 
 
 
0 : inaccurate descriptor of locus position based on probe location; duplicate gene      
1 : fdiff > 2, gene diff expressed at T = 0 HR        
2 : probe/gene name does not correspond to gene          
3 : histocompatibility/Igh group                
4:  already researched                  
5 : Gene lacks name (not yet researched)           
6 : Gene lacks formal name (not yet researched)              
7 : Gene formally named (not yet researched)          
8 : Gene not detected by original sorting, no diff exp. At T = 0 HR, diff exp at T = 24 HRhours        
9:  Involved in Immune Resonse; top priority              
   Table 1:  Candidate Genes Prioritized by Relevance 
 
 Of the 262 genes that were determined through formula-based data manipulation, 
only five appeared to be directly related to the immune system.  These five genes were 
selected for further rt RT-PCR analysis. 
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Analysis of Professor Boyartchuk’s T = 0 hr, T = 24 hr Candidate gene spreadsheet  
Genes previously researched by Dr. Boyartchuk’s lab were re-evaluated and 
labeled in order to incorporate additional candidate genes derived using a priori 
knowledge.  Originally, Dr. Boyartchuk had sorted for genes which, based upon his 
previous research and knowledge of the immune system, were likely candidates for 
further research.  To identify additional candidate genes, we sorted his sheet to find genes 
accurately described by its corresponding Affymetrix probe.  Of the 105 candidate probes 
identified as genomically relevant, we then sorted for genes differentially expressed at T 
= 0 hr (Table 2).  These genes were further analyzed to determine the direction of gene 
regulation following infection with Listeria (T = 24 hr).   
 
Gene T = 0 hr ID 
B 
signal 
average 
C signal 
average F-Diff ttest T = 24 hr ID 
B 
signal 
average 
C 
signal 
average F-Diff Ttest 
Oas3 1425374_at 163.40 476.00 -2.91 0.11 1425175_at 44.50 35.43 1.33 0.38 
Cd24a 1416034_at 2308.85 8833.50 -3.83 0.03 1448182_a_at 3163.60 4092.47 -1.29 0.02 
Cd24a 1437502_x_at 646.50 1940.40 -3.00 0.96 1416034_at 2729.83 3616.87 -1.33 0.05 
Cd24a 1448182_a_at 2717.75 9133.35 -3.36 0.06 1437461_s_at 192.50 213.03 -1.12 0.46 
Gbp1 1420549_at 65.35 436.40 -6.68 0.01 1420549_at 357.13 3096.03 -8.82 0.00 
G1p2 1431591_s_at 211.60 530.55 -2.51 0.03 1453939_x_at 387.60 376.60 1.04 0.79 
G1p2 1453939_x_at 33.60 57.60 -1.71 0.01 1431591_s_at 3345.67 3363.67 1.00 0.98 
Isg20 1419569_a_at 368.80 3108.35 -8.43 0.12 1419569_a_at 2450.90 2969.43 -1.21 0.14 
Il1rl1 1422317_a_at 15.70 83.45 -5.32 0.02 1425145_at 116.57 223.67 -2.13 0.14 
Il1rl1 1425145_at 78.85 419.50 -5.32 0.01 1422317_a_at 11.53 11.83 -1.02 0.92 
Klrc1 1425005_at 122.40 55.10 2.22 0.01 1425005_at 130.37 42.57 3.07 0.00 
Klrc1 1426182_a_at 108.60 35.55 3.05 0.02 1426182_a_at 50.27 37.03 1.43 0.25 
Klra7 1426171_x_at 112.90 35.65 3.17 0.01 1426171_x_at 77.17 7.63 10.72 0.01 
Klra7 1451664_x_at 5.30 13.75 -2.59 0.06 1451664_x_at 8.97 11.30 -1.26 0.18 
Ly6d 1416930_at 3037.65 397.05 7.65 0.02 1416930_at 1176.80 401.73 2.92 0.00 
Dfy 1432273_a_at 191.20 851.80 -4.46 0.03 1432273_a_at 125.57 294.23 -2.31 0.02 
Ifi202b 1421551_s_at 5.20 314.75 -60.53 0.01 1421551_s_at 22.53 1943.17 
-
165.81 0.03 
            1457665_x_at 1.87 2.70 -1.48 0.14 
Klra8 1425417_x_at 102.30 3.00 34.10 0.04 1425417_x_at 33.30 7.20 6.61 0.10 
Klf1 1418600_at 134.45 3162.65 -23.52 0.04 1418600_at 482.40 1182.37 -2.68 0.08 
Add2 1421975_a_at 8.50 87.40 -10.28 0.00 1421975_a_at 31.63 57.67 -1.82 0.00 
Add2 1451914_a_at 5.00 49.00 -9.80 0.01 1435287_at 65.73 102.43 -1.64 0.18 
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          1450442_at 72.97 99.47 -1.40 0.18 
  
          1451914_a_at 26.37 30.83 -1.15 0.71 
Ang 1450717_at 160.50 112.70 1.42 0.24 1438936_s_at 66.97 12.43 5.67 0.01 
            1438937_x_at 95.27 27.37 5.58 0.18 
            1450717_at 23.63 26.33 -1.05 0.89 
Ank1 1452512_a_at 6.25 106.45 -17.03 0.01 1419421_at 181.57 519.93 -3.01 0.04 
Ank1 1419421_at 220.55 1529.40 -6.93 0.03 1425677_a_at 138.03 251.17 -1.78 0.10 
Ank1 1425677_a_at 4.80 727.80 
-
151.63 0.01 1452512_a_at 19.37 44.67 -2.78 0.17 
Kel 1449057_at 94.30 2305.25 -24.45 0.01 1449057_at 370.03 854.97 -2.34 0.04 
Trim30 1417961_a_at 2293.60 891.05 2.57 0.05 1417961_a_at 3446.67 2631.67 1.31 0.04 
Trim30 1451860_a_at 1106.50 753.45 1.47 0.13 1451860_a_at 2471.60 2473.97 -1.00 0.96 
Trim30 1438716_at 200.20 3.65 54.85 0.07           
Trim30 1456494_a_at 916.80 329.65 2.78 0.14           
Sox6 1426018_a_at 17.00 125.70 -7.39 0.02 1427677_a_at 61.50 112.47 -1.83 0.05 
Sox6 1427677_a_at 3.70 304.55 -82.31 0.01 1434918_at 90.13 151.20 -1.67 0.10 
  
          1426018_a_at 23.20 40.73 -1.85 0.16 
Spna1 1421277_at 3.35 2039.30 
-
608.75 0.01 1421277_at 257.70 954.23 -3.71 0.00 
Spna1 1421278_s_at 40.65 1068.35 -26.28 0.03 1421278_s_at 446.77 820.83 -1.85 0.05 
Proz 1431721_a_at 68.45 42.75 1.60 0.05 1450201_at 3.27 6.57 -2.81 0.21 
Proz 1450201_at 83.70 31.10 2.69 0.03 1431721_a_at 8.93 3.67 2.59 0.22 
Tm4sf3 1420017_at 187.90 397.75 -2.12 0.05 1420017_at 87.93 137.40 -1.53 0.11 
Tm4sf3 1420018_s_at 10.85 33.15 -3.06 0.16 1424649_a_at 130.67 279.57 -2.09 0.12 
Tm4sf3 1420019_at 42.65 81.85 -1.92 0.01 1420018_s_at 5.50 14.93 -3.72 0.20 
Tm4sf3 1424649_a_at 1.80 413.25 
-
229.58 0.00 1420019_at 18.53 21.67 -1.12 0.69 
Trim10 1419311_at 120.80 3366.75 -27.87 0.04 1419311_at 777.43 1602.77 -2.07 0.03 
Trim12 1420648_at 162.15 88.25 1.84 0.03 1437432_a_at 569.00 1.93 399.73 0.01 
Trim12 1437432_a_at 369.55 1.40 263.96 0.14 1420648_at 49.83 26.13 1.86 0.06 
Trim34 1421550_a_at 734.75 220.45 3.33 0.38 1426093_at 44.20 275.53 -6.23 0.00 
Trim34 1424857_a_at 1682.80 69.05 24.37 0.08 1421550_a_at 801.10 221.77 3.63 0.00 
Trim34 1426092_a_at 180.55 48.40 3.73 0.02 1424857_a_at 1697.57 69.50 24.80 0.00 
Trim34 1426093_at 25.80 59.80 -2.32 0.01 1426092_a_at 238.30 62.30 3.87 0.01 
Ermap 1418909_at 200.05 3752.00 -18.76 0.06 1418909_at 725.70 1398.70 -2.02 0.09 
Cldn13 1422920_at 41.25 2039.50 -49.44 0.03 1422920_at 329.03 759.97 -2.55 0.10 
1110063G11Rik 1428108_x_at 186.15 4629.30 -24.87 0.06 1452666_a_at 1174.30 1755.93 -1.56 0.26 
1110063G11Rik 1452666_a_at 115.95 4588.40 -39.57 0.02 1428108_x_at 1188.13 1719.60 -1.53 0.29 
Alad 1424877_a_at 296.70 4099.35 -13.82 0.06 1424877_a_at 342.30 1857.93 -5.80 0.02 
Hemgn 1418199_at 80.50 5473.95 -68.00 0.04 1418199_at 1038.60 2189.30 -2.23 0.08 
Tnfrs14 1452425_at 10.20 111.75 -10.96 0.01           
Snx6 1425148_a_at 859.85 572.15 1.50 0.23 1457259_at 76.37 176.63 -2.31 0.00 
Snx6 1429497_s_at 636.95 475.30 1.34 0.79 1451602_at 48.63 2.87 26.14 0.03 
Snx6 1451602_at 65.40 2.85 22.95 0.02 1425148_a_at 410.80 445.50 -1.09 0.12 
  
          1429497_s_at 494.47 542.67 -1.10 0.20 
  
          1447234_s_at 315.73 319.40 -1.02 0.86 
Xpo7 1415682_at 326.30 2151.50 -6.59 0.07 1415682_at 501.43 891.23 -1.80 0.10 
Xpo7 1439411_a_at 847.00 5557.35 -6.56 0.22 1446826_at 15.80 22.17 -1.57 0.35 
            1435814_at 49.10 42.63 1.21 0.58 
Slc4a1 1431743_a_at 6.45 888.25 
-
137.71 0.11 1434502_x_at 2300.23 3281.17 -1.43 0.02 
Slc4a1 1416464_at 192.20 6752.95 -35.14 0.04 1416464_at 2154.87 3145.03 -1.47 0.07 
Slc4a1 1434502_x_at 140.25 5983.30 -42.66 0.03 1431743_a_at 141.07 246.27 -1.77 0.13 
Ifi205 1452349_x_at 1319.70 735.25 1.79 0.05 1452349_x_at 3308.37 1908.47 1.73 0.00 
Ifi205 1426906_at 2713.20 1498.05 1.81 0.04 1452348_s_at 2227.87 1911.40 1.16 0.03 
Ifi205 1452231_x_at 3842.55 2487.00 1.55 0.01 1426906_at 3255.57 3521.10 -1.08 0.15 
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Ifi205 1452348_s_at 942.35 604.30 1.56 0.18 1452231_x_at 3577.70 3798.97 -1.06 0.28 
Ifrd2 1451016_at 320.70 1333.95 -4.16 0.11 1451016_at 374.90 608.23 -1.64 0.04 
Ifngr 1448167_at 1193.75 647.25 1.84 0.11 1448167_at 299.27 248.37 1.21 0.24 
Irf5 1460231_at 675.45 394.35 1.71 0.57 1460231_at 399.23 267.30 1.51 0.06 
Ian1 1424374_at 2149.80 1430.55 1.50 0.02 1424374_at 1271.20 1061.37 1.19 0.09 
Tnfaip2 1416273_at 277.90 743.75 -2.68 0.10 1438854_x_at 75.20 109.73 -1.47 0.04 
Tnfaip2 1438855_x_at 263.80 648.95 -2.46 0.05 1416273_at 724.93 650.70 1.12 0.46 
Il7r 1448575_at 1568.05 795.35 1.97 0.09 1448575_at 426.83 448.53 -1.06 0.71 
Il7r 1448576_at 649.75 233.45 2.78 0.71 1448576_at 168.03 170.20 -1.00 0.99 
Il21r 1450456_at 306.30 127.55 2.40 0.06 1450456_at 175.00 98.40 1.80 0.03 
Irak1 1438120_x_at 347.65 168.25 2.07 0.08 1448668_a_at 218.93 151.83 1.42 0.09 
Irak1 1438857_x_at 337.65 263.55 1.28 0.12 1460649_at 231.77 190.40 1.21 0.16 
Irak1 1448668_a_at 435.10 369.70 1.18 0.19 1438857_x_at 105.90 98.50 1.07 0.53 
Irak1 1460649_at 566.05 601.70 -1.06 0.68 1438096_a_at 364.83 354.77 1.02 0.89 
Ian6 1427891_at 1191.20 755.05 1.58 0.11 1456762_at 118.13 70.70 1.66 0.02 
  
          1427891_at 512.47 461.10 1.11 0.06 
Il1b 1449399_a_at 397.20 591.10 -1.49 0.16 1449399_a_at 2247.97 2267.97 -1.02 0.88 
Il1f8 1425715_at 126.30 186.15 -1.47 0.02 1425715_at 36.00 50.00 -1.36 0.15 
Itgb3 1421511_at 86.40 124.25 -1.44 0.18 1421511_at 30.43 53.40 -1.69 0.20 
            1455257_at 137.40 109.37 1.33 0.36 
Camp 1419691_at 1319.60 547.65 2.41 0.12 1419691_at 189.63 288.00 -1.57 0.13 
Hamp 1419196_at 1108.50 295.55 3.75 0.13 1419197_x_at 45.80 47.23 -1.02 0.90 
Hamp 1419197_x_at 951.95 273.90 3.48 0.17 1419196_at 35.43 35.67 1.00 0.99 
Ifit1 1450783_at 213.45 248.20 -1.16 0.08 1435414_s_at 400.70 464.40 -1.16 0.15 
  
          1450783_at 2628.33 2466.57 1.07 0.60 
Tap1 1420274_at 17.10 25.20 -1.47 0.02 1449802_x_at 8.43 5.07 1.69 0.08 
Tap1 1420275_at 485.25 417.45 1.16 0.30 1416016_at 1706.63 1289.33 1.33 0.10 
Tap1 1448177_at 17.55 15.55 1.13 0.01 1420274_at 8.47 13.00 -1.54 0.16 
Tap1 1449803_x_at 19.90 7.60 2.62 0.13 1448177_at 32.37 36.93 -1.17 0.47 
Tap1 1416016_at 1167.25 584.50 2.00 0.12 1420275_at 147.97 132.33 1.13 0.54 
Cmkor1 1417625_s_at 630.25 355.60 1.77 0.84 1417625_s_at 202.97 144.70 1.44 0.14 
C4 1418021_at 2331.55 1657.80 1.41 0.05 1418021_at 1024.47 1137.47 -1.10 0.50 
Ctse 1418989_at 309.90 8815.65 -28.45 0.10 1418989_at 1486.03 3112.60 -2.18 0.06 
Lsp1 1417756_a_at 3098.75 2035.80 1.52 0.04 1417756_a_at 1103.33 713.87 1.54 0.02 
Ifi205 1452349_x_at 1319.70 735.25 1.79 0.05 1452349_x_at 3308.37 1908.47 1.73 0.00 
Ifi205 1426906_at 2713.20 1498.05 1.81 0.04 1452348_s_at 2227.87 1911.40 1.16 0.03 
Ifi205 1452231_x_at 3842.55 2487.00 1.55 0.01 1426906_at 3255.57 3521.10 -1.08 0.15 
Ifi205 1452348_s_at 942.35 604.30 1.56 0.18 1452231_x_at 3577.70 3798.97 -1.06 0.28 
1300013J15Rik 1418395_at 86.15 5.10 16.89 0.02 1418395_at 3.50 3.47 1.49 0.74 
1110005A03Rik 1451448_a_at 578.30 180.15 3.21 0.76 1451448_a_at 264.83 110.53 2.40 0.00 
            1453485_s_at 242.17 100.07 2.42 0.00 
2610511O17Rik 1452665_at 208.90 88.90 2.35 0.11 1452665_at 113.37 66.23 1.73 0.03 
Blame-pending 1425294_at 360.10 152.65 2.36 0.13           
Csf2rb1 1421326_at 313.05 233.30 1.34 0.10 1455660_at 889.33 727.83 1.22 0.13 
Csf2rb1 1450200_s_at 122.15 31.75 3.85 0.03 1450200_s_at 204.40 143.10 1.39 0.20 
  
          1421326_at 643.20 571.17 1.13 0.34 
Itsn 1421192_a_at 7.65 8.45 -1.10 0.03 1435885_s_at 42.13 85.83 -2.06 0.03 
Itsn 1425899_a_at 93.80 178.15 -1.90 0.07 1452338_s_at 79.50 108.57 -1.37 0.05 
Itsn 1435884_at 30.50 53.00 -1.74 0.03 1425899_a_at 59.20 78.67 -1.34 0.08 
Itsn 1452338_s_at 220.25 407.45 -1.85 0.08 1435884_at 59.00 78.97 -1.34 0.09 
Itsn 1435885_s_at 241.50 452.35 -1.87 0.09 1459621_at 24.97 49.23 -1.81 0.23 
            1421192_a_at 2.10 3.23 -1.38 0.47 
Mpeg1 1427076_at 2597.95 1582.70 1.64 0.05 1427076_at 2800.20 2036.33 1.38 0.00 
Cxcl15 1421404_at 30.50 9.00 3.39 0.02 1421404_at 5.93 17.53 -3.14 0.04 
Mif 1416335_at 2052.85 1222.35 1.68 0.03 1416335_at 1587.27 1387.20 1.14 0.26 
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4933425F03Rik 1431336_at 56.10 92.85 -1.66 0.03 1451204_at 3.97 12.67 -2.94 0.07 
4933425F03Rik 1451204_at 168.65 100.95 1.67 0.06 1431336_at 20.60 14.20 1.48 0.20 
Cxcr3 1449925_at 576.85 306.40 1.88 0.75 1449925_at 106.13 95.00 1.12 0.29 
Cxcr6 1422812_at 137.40 61.25 2.24 0.02 1425832_a_at 185.80 114.40 1.63 0.02 
Cxcr6 1425832_a_at 432.35 241.95 1.79 0.18 1422812_at 93.93 61.53 1.52 0.19 
Epor 1423344_at 225.10 750.70 -3.33 0.04 1423344_at 187.90 339.73 -1.84 0.04 
Lifr 1425107_a_at 256.45 113.50 2.26 0.08 1425107_a_at 33.17 25.03 1.39 0.28 
Lifr 1450207_at 51.20 55.40 -1.08 0.03 1450207_at 2.63 2.63 1.07 0.88 
Stat4 1448713_at 365.10 181.50 2.01 0.14 1448713_at 206.80 161.00 1.28 0.02 
Map2k3 1425456_a_at 356.75 810.65 -2.27 0.14 1425456_a_at 176.60 259.37 -1.48 0.04 
Map2k3 1451714_a_at 515.30 1066.65 -2.07 0.41 1451714_a_at 337.77 472.13 -1.39 0.06 
Cxcl9 1418652_at 591.30 304.90 1.94 0.86 1456907_at 907.93 587.57 1.55 0.01 
            1418652_at 3811.53 3778.93 1.00 0.98 
Ccl19 1449277_at 2039.20 1496.45 1.36 0.05 1449277_at 959.17 840.97 1.14 0.10 
Pglyrp 1449184_at 317.65 165.50 1.92 0.10 1449184_at 98.63 72.40 1.39 0.14 
Il9r 1421570_at 13.65 50.40 -3.69 0.01 1421570_at 2.57 8.83 -3.04 0.10 
Socs3 1416576_at 127.00 33.05 3.84 0.05 1416576_at 587.00 375.27 1.55 0.03 
Socs3 1455899_x_at 168.10 105.65 1.59 0.03 1456212_x_at 963.43 839.87 1.15 0.26 
Socs3 1456212_x_at 77.60 96.10 -1.24 0.01 1455899_x_at 1105.07 942.40 1.16 0.28 
Ccl12 1419282_at 5.30 8.00 -1.51 0.00 1419282_at 328.30 345.07 -1.04 0.79 
Ccl7 1421228_at 10.40 35.40 -3.40 0.04 1421228_at 246.20 196.80 1.24 0.38 
Lepr 1425644_at 175.85 71.95 2.44 0.03 1456156_at 44.70 22.00 2.02 0.02 
Lepr 1425873_a_at 23.20 14.75 1.57 0.16 1425644_at 29.13 14.17 2.00 0.16 
Lepr 1425875_a_at 209.75 189.70 1.11 0.03 1425873_a_at 14.33 12.13 1.22 0.59 
            1425875_a_at 37.10 40.43 -1.04 0.90 
Cks2 1417457_at 529.20 2021.20 -3.82 0.54 1417458_s_at 682.90 1051.80 -1.55 0.17 
Cks2 1417458_s_at 689.90 2184.85 -3.17 0.51 1417457_at 581.40 884.27 -1.55 0.25 
Il1rn 1423017_a_at 23.85 70.70 -2.96 0.02 1451798_at 1037.10 720.27 1.45 0.08 
Il1rn 1425663_at 60.65 184.95 -3.05 0.01 1423017_a_at 812.63 546.17 1.48 0.11 
Il1rn 1451798_at 97.25 114.20 -1.17 0.02 1425663_at 241.07 213.93 1.11 0.57 
Fn3k 1418311_at 9.00 362.75 -40.31 0.02 1418311_at 53.87 129.27 -2.65 0.12 
Rhced 1417049_at 129.10 3610.70 -27.97 0.02 1417049_at 647.70 1328.90 -2.08 0.07 
Hmbs 1436930_x_at 189.80 1935.20 -10.20 0.02 1436930_x_at 766.43 1509.23 -2.01 0.06 
Hmbs 1426475_at 359.35 5642.65 -15.70 0.13 1426475_at 1117.60 1912.23 -1.73 0.10 
Rhag 1419014_at 58.50 1731.60 -29.60 0.01 1419014_at 637.70 1292.63 -2.07 0.07 
Sgne1 1423150_at 4.30 103.90 -24.16 0.00 1423150_at 3.43 26.53 -10.86 0.05 
Slc22a4 1417639_at 4.95 78.70 -15.90 0.03 1417639_at 24.33 61.33 -2.87 0.10 
Epb4.2 1417338_at 13.65 897.70 -65.77 0.02 1417337_at 196.57 437.40 -2.20 0.05 
Epb4.2 1417337_at 7.65 372.25 -48.66 0.02 1417338_at 115.37 197.00 -1.87 0.24 
Gypa 1423016_a_at 81.40 3941.30 -48.42 0.02 1423016_a_at 1103.37 1910.40 -1.74 0.07 
Gypa 1425643_at 15.30 2877.80 
-
188.09 0.00 1425643_at 949.80 1678.87 -1.76 0.08 
Slc7a2 1426008_a_at 117.30 64.10 1.83 0.03 1426008_a_at 41.37 19.73 2.09 0.01 
Slc7a2 1450435_at 244.80 335.95 -1.37 0.04 1422648_at 36.00 26.20 1.38 0.02 
Slc7a2 1450703_at 64.25 27.70 2.32 0.01 1450435_at 64.87 86.77 -1.33 0.13 
Slc7a2 1422648_at 66.65 7.25 9.19 0.03 1450703_at 11.20 5.13 2.82 0.18 
Rpgrip1 1431357_a_at 8.25 9.35 -1.13 0.01 1421144_at 963.63 55.63 17.42 0.00 
Rpgrip1 1421144_at 1914.30 138.40 13.83 0.06 1454231_a_at 33.77 22.50 1.51 0.12 
Rpgrip1 1451785_at 24.60 37.40 -1.52 0.01 1431357_a_at 2.20 3.20 -1.20 0.77 
Rpgrip1 1454231_a_at 104.05 93.80 1.11 0.01 1451785_at 6.90 7.27 1.05 0.94 
3010033P07Rik 1426958_at 243.20 266.25 -1.09 0.08 1426958_at 178.37 116.20 1.53 0.00 
3010033P07Rik 1433689_s_at 7629.50 7550.05 1.01 0.03 1434624_x_at 2263.23 270.17 8.55 0.00 
3010033P07Rik 1434624_x_at 2678.25 223.40 11.99 0.02 1433689_s_at 3829.90 3981.13 -1.04 0.55 
Car2 1448752_at 913.65 12898.95 -14.12 0.14 1448752_at 2715.63 3725.23 -1.37 0.03 
Icam4 1422930_at 55.30 631.50 -11.42 0.01 1422930_at 75.97 221.27 -3.10 0.04 
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Trfr 1422966_a_at 181.80 1942.55 -10.69 0.03 1425546_a_at 317.70 347.67 -1.09 0.42 
Trfr 1422967_a_at 69.50 571.80 -8.23 0.03 1422967_a_at 66.63 109.83 -1.66 0.03 
Trfr 1452661_at 721.30 4613.65 -6.40 0.42 X57349_M_at 28.83 62.53 -2.23 0.04 
Trfr X57349_3_at 85.05 851.30 -10.01 0.02 X57349_3_at 208.87 393.07 -1.93 0.06 
Trfr X57349_5_at 35.70 313.10 -8.77 0.01 1452661_at 1179.03 1993.93 -1.72 0.06 
Trfr X57349_M_at 19.75 198.10 -10.03 0.01 X57349_5_at 36.17 71.00 -2.04 0.07 
            1422966_a_at 372.77 714.70 -2.01 0.09 
Vig1-pending 1436058_at 620.60 6858.40 -11.05 0.91 1436058_at 4307.17 4653.20 -1.09 0.39 
Vig1-pending 1421008_at 208.05 2112.30 -10.15 0.05 1421009_at 3114.80 3023.60 1.02 0.84 
Vig1-pending 1421009_at 182.85 2072.70 -11.34 0.07 1421008_at 2613.63 2609.67 -1.01 0.97 
Table 2:  Differential Expression of 105 Genes at T = 0 hr and T = 24 hr. Note that blue colored probe 
identification represents incorrect probe location; black probe identification represents partial incorrect 
probe; red colored probe identification represents accurate probe location. 
 
 The red, black, and blue colored probe identification numbers respectively 
indicate the accuracy of the probe in representing its corresponding gene.  For example, 
the Trfr gene has six probes assigned to it on the Affymetrix gene chip.  Referencing 
their location using the University of California - Santa Cruz Genome Bioinformatics 
website, the probes were compared with more recent gene location data.  Probes which 
were completely or partially inaccurate were designated blue and black, respectively.  
Accurate probes were labeled red.  Thus, a probe’s categorization weighed heavily in 
considering its signal value. 
BalbC mice exhibited relatively high expression at T = 0 hr with no differential 
expression at T = 24 hr compared to Black6 mice for 27 of the genes (Table 2).  BalbC 
mice maintained relatively high expression compared to the Black6 mice at T = 0 hr and 
T = 24 hr for 10 of the genes.  Black6 mice had relatively high expression at T = 0 hr but 
no differential expression at T = 24 hr compared to BalbC mice for 5 of the genes.  
Black6 mice maintained relatively high expression compared to the BalbC mice at T = 0 
hr and T = 24 hr for 4 of the genes.   
Due to time limitations, only two of the possible candidates from this spreadsheet 
(Dfy, Snx6) were analyzed during the next stage of rt RT-PCR analysis.   
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Real-Time Reverse Transcriptase Polymersase Chain Reaction (rt RT-PCR)  
 Twenty-three top priority candidate genes were analyzed.  These genes were 
selected throughout the sorting methods described above due to a high degree of 
supporting data, practicality in terms of primer development, and relevance to the 
immune system.  Ideally, the data obtained from the rt RT-PCR would coincide with the 
Black6 to BalbC gene chip fold-difference values. 
 The rt RT-PCR was performed using liver and spleen samples from both the 
Black6 and BalbC mouse lines at T = 0 hr and T = 24 hr (Table 3). 
GENE 
C(t) 
Black6 
(1) 
C(t) 
Black6 
(2) 
STD 
DEV 
C(t) 
BalbC 
(3) 
C(t) 
BalbC 
(4) 
STD 
DEV ttest 
DELTAC 
(t) 
C(t) 
Black6 
(1) 
C(t) 
Black6 
(2) 
STD 
DEV 
C(t) 
BalbC 
(3) 
C(t) 
BalbC 
(4) 
STD 
DEV ttest 
DELTAC 
(t) 
Chi3l3 16.60 17.90 0.92 16.60 16.40 0.14 0.45 0.75 17.00 17.50 0.35 18.30 18.20 0.07 0.14 -1.00 
  24.20 19.13 3.58 21.07 21.96 0.63 0.96 0.15 17.32 14.27 2.16 20.09 21.46 0.97 0.15 -4.98 
  
                                
arl2bp 18.50 18.30 0.14 18.80 18.90 0.07 0.09 -0.45 17.20 17.00 0.14 17.20 17.90 0.49 0.41 -0.45 
  
                                
agtrl1 21.01 19.11 1.34 20.20 19.60 0.42 0.89 0.16 19.55 20.18 0.44 20.26 20.07 0.13 0.51 -0.30 
  
                                
pim1 19.60 19.20 0.28 20.00 19.90 0.07 0.21 -0.55 18.40 18.30 0.07 19.10 18.60 0.35 0.29 -0.50 
  
                                
dad1 18.70 19.40 0.49 18.60 18.60 0.00 0.42 0.45 18.50 19.10 0.42 18.70 19.10 0.28 0.81 -0.10 
  
                                
serpinb6c 19.60 20.50 0.64 20.20 20.70 0.35 0.54 -0.40 20.90 20.30 0.42 20.40 20.10 0.21 0.44 0.35 
  28.76 26.63 1.51 28.60 28.08 0.37 0.65 -0.64 27.28 27.56 0.20 28.23 28.32 0.06 0.08 -0.86 
  
                                
ppp1cb 18.02 18.83 0.57 16.14 16.95 0.57 0.08 1.88 15.97 15.38 0.42 17.19 17.49 0.22 0.07 -1.67 
  14.73 14.54 0.13 14.06 14.07 0.00 0.10 0.57 14.89 14.02 0.61 14.49 22.21 5.46 0.50 -3.90 
  15.69 15.09 0.43 15.04 14.24 0.56 0.28 0.75 14.96 14.67 0.20 15.36 14.42 0.66 0.90 -0.08 
  16.94 16.34 0.42 16.15 16.01 0.10 0.30 0.56 16.41 16.05 0.26 16.21 16.06 0.10 0.71 0.09 
  
                                
ptp4a2 15.04 14.05 0.70 14.25 14.29 0.03 0.68 0.27 15.22 13.65 1.11 14.09 28.03 9.85 0.51 -6.63 
  15.25 14.82 0.31 14.72 14.38 0.24 0.22 0.49 15.37 14.75 0.44 15.44 15.55 0.08 0.38 -0.44 
  16.66 16.58 0.06 15.88 15.97 0.06 0.01 0.70 16.25 16.13 0.08 16.32 16.03 0.21 0.94 0.01 
  
                                
ssr1 15.25 22.94 5.43 18.34 33.01 10.37 0.53 -6.58 31.71 33.03 0.93 17.08 27.88 7.64 0.31 9.90 
  15.65 14.84 0.58 17.22 15.34 1.33 0.46 -1.03 14.62 17.97 2.37 15.59 15.68 0.07 0.76 0.66 
  17.48 17.13 0.24 16.97 17.42 0.32 0.73 0.11 17.03 17.26 0.16 17.38 17.05 0.23 0.77 -0.07 
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  26.83 26.50 0.23 25.47 25.87 0.28 0.07 0.99 26.38 26.07 0.22 27.63 27.80 0.12 0.03 -1.49 
  
                                
Dfy 20.38 20.39 0.01 19.81 19.96 0.10 0.09 0.50 21.95 21.15 0.57 21.55 20.70 0.60 0.54 0.42 
  20.60 20.64 0.03 20.04 20.18 0.10 0.07 0.51 19.36 19.58 0.15 20.09 20.15 0.04 0.09 -0.65 
  21.35 21.20 0.11 21.21 19.99 0.86 0.47 0.67                 
  
                                
AI447904 17.20 17.36 0.11 17.90 17.89 0.00 0.08 -0.61 17.01 17.98 0.69 17.94 17.88 0.04 0.55 -0.41 
  18.29 18.25 0.03 18.19 18.34 0.10 0.96 0.00 16.82 17.42 0.43 17.43 17.45 0.01 0.48 -0.32 
  
                                
Chi3l4 29.01 27.89 0.79 31.59 28.22 2.38 0.54 -1.45 28.35 29.03 0.48 29.07 31.02 1.37 0.38 -1.35 
  
                                
Slc15a2 25.03 24.75 0.20 28.87 26.38 1.76 0.27 -2.73 24.37 25.02 0.46 29.32 29.68 0.26 0.01 -4.80 
  
                                
Gpr43 21.34 20.37 0.69 20.05 20.68 0.45 0.50 0.49 17.30 18.81 1.07 21.24 21.43 0.13 0.14 -3.28 
  23.17 22.39 0.55 23.09 19.71 2.39 0.56 1.38 21.78 23.21 1.01 22.89 23.88 0.70 0.43 -0.89 
  
                                
zfp52 22.44 22.25 0.13 21.96 22.34 0.27 0.48 0.20 21.32 21.84 0.37 22.37 22.33 0.03 0.20 -0.77 
  23.41 23.52 0.08 22.27 23.37 0.77 0.45 0.64 25.80 24.81 0.70 26.00 25.78 0.16 0.44 -0.59 
  
                                
tgfb1i4 20.11 19.96 0.11 19.73 19.57 0.11 0.07 0.39 19.52 22.06 1.80 20.63 19.75 0.62 0.72 0.60 
  25.13 24.35 0.55 24.40 25.24 0.59 0.90 -0.08 26.81 26.16 0.46 25.93 25.66 0.19 0.25 0.69 
                                  
IL1f9 30.03 31.23 0.85 27.73 29.47 1.23 0.21 2.03 27.65 28.39 0.53 25.94 N/A N/A N/A N/A 
  
                                
IL2ra 31.28 29.17 1.49 28.78 30.28 1.06 0.65 0.70 29.33 26.90 1.72 28.96 30.22 0.89 0.42 -1.47 
  
                                
IL2rb 23.27 23.98 0.50 23.56 24.84 0.90 0.53 -0.58 24.38 23.96 0.30 23.85 24.15 0.21 0.59 0.17 
  
                                
IL4ra 22.88 N/A N/A 25.19 25.34 0.10 N/A N/A 22.97 23.16 0.13 25.94 25.85 0.06 0.01 -2.83 
  
                                
Ccl24 23.67 24.04 0.26 21.81 23.43 1.15 0.36 1.23 22.88 22.13 0.53 23.00 27.71 3.33 0.44 -2.85 
  
                                
Klrc 22.84 22.50 0.24 23.37 23.65 0.20 0.07 -0.84 23.53 22.35 0.84 24.15 24.03 0.09 0.30 -1.15 
  
                                
Snx6 23.12 23.21 0.07 23.46 21.73 1.22 0.63 0.56 23.03 22.46 0.41 21.87 22.07 0.14 0.20 0.77 
  Table 3:  Real-Time RT-PCR Results for 18 genes at T = 0 hr and T = 24 hr  
The genes above agreed with their supporting gene chip data in that none 
exhibited large, statistically significant differential expression at T = 0 HR (i.e. exhibiting 
a Black6 to BalbC ratio greater than 2 or -2, with an error value below 0.05).   Gene 
Slc15a2 exhibited differential expression at T = 24 hr (Table 3).  Allowing for an 
increase in acceptable error from 0.05 to 0.15, two more candidate genes, Chi3l3 and 
Gpr43, exhibit differential expression at T = 24 hr. 
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The Slc15a2 gene rt RT-PCR analysis correlated with the genechip analysis.  
Though Slc15a2 did not exhibit differential expression at T = 0 hr, the gene in the Black6 
(Listeria resistant) mouse exhibited a statistically significant 6.35 fold difference in 
expression compared to the BalbC mouse.  This gene chip data agreed reasonably well 
with the statistically significant 4.80 expression fold difference shown during the rt RT-
PCR analysis.  To further characterize Slc15a2’s role during the mouse’s immune 
response to Listeria, the gene was analyzed via rt RT-PCR using T = 48 hr RNA.  Due to 
inconsistencies in results derived using liver RNA, spleen RNA was utilized during the 
run (Table 4).  Both organs are major sites of the innate immune system response, and 
are suitable for measuring gene expression (Boyartchuk, 2004).  Analysis at T = 48 hr 
illustrated a reversal in gene expression, with a statistically significant 2.81 fold 
difference exhibited by BalbC to Black6 mice.   
 
GENE 
C(t) 
Black6 
(1) 
C(t) 
Black6 
(2) 
STD DEV C(t) BalbC (3) 
C(t) 
BalbC (4) STD DEV ttest 
DELTAC 
(t) 
Slc15a2 26.91 26.35 0.40 24.20 23.45 0.53 0.03 2.81 
Table 4: Rt RT-PCR Results for Slc15a2 at T = 48 HR hr using spleen RNA. 
 
These results for Slc15a2 indicate that the gene is inactive prior to infection and 
becomes activated in Listeria-resistant mice upon infection before gradually slowing and 
eventually stopping expression sometime after 24 hours.  The BalbC mice may also 
activate the Slc15a2 gene in response to infection, though their response appears to be 
delayed in spleen cells.  
The rt RT-PCR analysis of Chi3l3 illustrated a 4.98 fold expression difference (t-
test = 0.15) at T = 24 hr exhibited by Black6 mice compared to BalbC.  The gene chip 
 54 
data, with an insignificant T = 0 hr fold difference, displayed a T = 24 hr Black6 to 
BalbC difference of 11.45 fold difference and a 0.00 level of error.  Both methods of 
analysis agreed as to the direction of gene expression, though there was a significant 
difference in the level of differential expression between strains.  This suggests active 
Chi3l3 gene expression in resistant Black6 mice (but not the susceptible BalbC) 24 hours 
after Listeria infection.  However, the results are hampered by nearly significant large 
fold differences exhibited by the T = 0 hr gene chip data.  If significant, drawing 
conclusions about the overall expression differences between mice strains would be 
premature due to the contradictory nature between the gene chip and the rt RT-PCR data.  
Further testing is necessary to verify Chi3l3’s candidacy. 
The third candidate gene, Gpr43, did not generate statistically significant rt RT-
PCR results to verify the gene chip data.  According to the gene chip, Gpr43 was 
differentially expressed (with 0.00 error) by Black6 mice 2.03 times over that of BalbC 
mice 24 hours post-infection.  Rt RT-PCR analysis showed 3.28 differential expression in 
the same direction.  These results would appear to coincide well except that the rt RT-
PCR analysis had an t-test error value of 0.14, in excess of the typical maximum error of 
0.05.  Thus, the results are unreliable and further testing is also necessary to verify 
Gpr43’s candidacy.  
 
 
Mapping Candidate Genes  
 To confirm the publicly listed genome locations of the candidate genes, mapping 
analysis was employed.  This process consisted of performing a rt RT-PCR experiment 
using the desired gene and an RNA template consisting of all 13 CXB RI mouse strains.  
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The results were entered into a mapping program for location analysis.  Two candidate 
genes, Chi3l3 and Slc15a2, were mapped on the CXB RI mouse RNA liver set and 
mapped using the MapManager QTX.  In both instances, the genes mapped 
inconclusively. 
The first mapping experiment involved the T = 24 hr liver CXB RI mouse 
mapping line for the Chi3l3 gene.  The software was unable to pinpoint a location due to 
unreliable cycle values from the rt RT-PCR.  The liver mapping RNA was discarded as 
repeated experiments did not yield conclusive results (Figure 5).   
 
Figure 5:  T=24 hr liver Chi3l3 mapping results using Map Manager QTX program. Chi3l3 did 
not map properly on the CXB RI panel. 
 
Ideally, the lines representing up or downregulation of Chi3l3 in each CXB mouse would 
fall into a down or up position on the map.  The arbitrary nature of the lines denotes 
statistically unreliable RNA expression. 
The Slc15a2 gene similarly mapped inconclusively using the T = 24 hr liver 
mapping RNA.  Due to a critical shortage of stock liver mapping RNA, T = 24 hr spleen 
mapping RNA was diluted and tested with the Slc15a2 gene (Figure 6).  Results from 
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this reaction suggested a gene location on chromosome 16, though one of the thirteen 
mice RNAs did not correspond with the publicly listed expression levels.  This mouse, #1 
ideally would exhibit upregulation to properly map to chromosome 16.   
 
  Figure 6: T=24 hr spleen Slc15a2 mapping results using Map Manager QTX program. 
 
 
A subsequent unsuccessful attempt prompted a third mapping experiment using T 
= 48 hr spleen RNA using the aberrant mouse RNA.  This mapping experiment 
confirmed the contradictory evidence derived in the first experiment (mouse #1 exhibited 
downregulation instead of the predicted upregulation).  Since the gene expression profile 
on the mapping RNA does not fully match the known profile, the mapping results for 
Slc15a2 are still inconclusive (Figure 7).  Though the program suggested a location on 
chromosome 9 (row highlighted in Figure 8), by looking at the table, it is clear that 
chromosome 16 – the predicted chromosome – could also be the correct location (yellow 
arrow in Figure 8).  It is likely that the program would have suggested chromosome 16 if 
mouse #1 showed the predicted upregulation. 
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Figure 7: T=48 spleen Slc15a2 mapping results using Map Manager QTX program. 
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Figure 8: Mapping Data for Slc15a2 using T = 48 hr spleen mRNA.  Yellow highlight denotes program’s 
suggested gene location.  Yellow arrow denotes publicly listed gene location.  Our inability to reconcile via 
rt RT-PCR mouse #1’s expression with the known values left Slc15a2 inconclusively mapped. 
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DISCUSSION 
 
 
Our results for Slc15a2 illustrate selective activation upon infection with Listeria 
in resistant Black6 mice.  Twenty-four hours after infection, Black6 mice had produced 
Slc15a2’s corresponding mRNA, encoding solute carrier family 15 (H+/peptide 
transporter), member 2 [PEPT2], at least 4.80 fold above baseline production.  However, 
this production apparently ceases forty-eight hours after infection.  Slc15a2 was mapped 
inconclusively to chromosome 16, in near agreement with public databases (NCBI, 
Stanford Source).   Interestingly, at T = 48 HR hr, the BalbC mice showed 2.81 fold 
expression over Black6 mice, suggesting that the Listeria-sensitive mice may have 
mutations hindering effective Slc15a2 transcription. 
The candidate gene Slc15a2 is involved in oligo-peptide transport across cellular 
membranes, notably in areas of the kidney and brain (NP 067276, 2004).  In mice, 
Slc15a2 encodes the protein PEPT2.  PEPT2 is a low capacity/high affinity oligo-peptide 
transport linked to neurotransmission and/or metabolism in the central nervous system.  
Specifically, PEPT2 has been shown to regulate neuropeptide homeostasis at the blood-
cerebrospinal fluid interface (Rubio-Aliaga, et al, 2000).   
The transporter operates in an electrogenic mode through coupling substrate 
influx to proton movement down an inwardly-directed proton gradient.  Radiation hybrid 
analysis reveals the PEPT2 gene to be localized close to D16Mit4 and D16Mit59 on 
central mouse chromosome 16. This region shows a conserved synteny with human 
chromosome 3 and the human PEPT2 gene localizes on chromosome 3q13.3–q21 
(Rubio-Aliaga, et al, 2000).   
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The human equivalent of PEPT2, Human Hþ/peptide cotransporter 2 (hPEPT2, 
SLC15A2), is expressed in a variety of tissues including the kidney, lung, and brain 
(Shen et al, 2003).  PEPT2 mediates the uphill transport of di- and tripeptides.  hPEPT2 
can transport a wide variety of peptide-like drugs such as b-lactam antibiotics and some 
angiotensin converting enzyme inhibitors, as these drugs are structurally similar to small 
peptides. Thus, hPEPT2 transports both nutrients and drugs (Terada et al, 2004).  
Slc15a2 may play a role in the innate immune response in both mice and humans 
in the transport of critical messenger peptides.  In immune system related organs, such as 
the spleen, liver, and kidney and in the brain, PEPT2 transporters could be responsible for 
mobilizing the body’s response to infection.  Without PEPT2, the body may not be able 
to coordinate its innate immune response during the critical 24 hours following Listeria 
infection. 
Future work will focus on repeating our analysis of the Slc15a2 gene.  Ideally 
future mapping experiments will verify the location of Slc15a2 with the publicly listed 
markers.  Long-term research could feasibly concern biochemically characterizing 
immune system molecules dependent upon Slc15a2 for neurotransmission and transport 
across cellular membranes.  
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Appendix A: Name, Function, and Priority of 213 Genes Identified as Differentially Expressed 
at T = 0 Hrs 
Gene Name Gene Function Associated Protein 
Ly6d Defense Response 
Lymphocyte antigen 6 complex, locus 
D 
Ly6a T-cell activiation 
Lymphocyte antigen 6 complex, locus 
A 
Ly108 
immunoglobin receptor expressed 
prodominantly on hematopoeitic cells lymphocyte antigen 108 
Apobec3 RNA editing enzyme Apolipoprotein B editing complex 3 
H2-Q7 
antigen processing and presentation; 
immune response histocompatibility 2, Q region lucus 7 
H2-Ob immune response; antigen processing 
histocompatibility 2, O region beta 
locus 
H2-Ea 
positive regulation of immune response; 
antigen presentation 
histocompatibility 2, class II antigen E 
alpha 
H2-Q1 antigen presentation; defense response histocompatibility 2, Q region locus 1 
H28 involved in immune response histocompatibility 28 
Gclm 
subunit of rate limiting enzyme in the 
GSH biosynthesis pathway; possible HIV 
regulation 
glutamate-cysteine liagse, modifier 
subunit 
Ifi202b 
interferon-activatable; involved in 
immune response interferon activated gene 202B 
Il1rl1 
produced by activated macrophages; 
involved in inflammatory response interleukin 1 receptor-like 1 
Klra8 
encodes natural killer cell specific 
receptor 
killer cell lectin-like receptor, 
subfamily A, member 8 
Klrc1 
entirely localized in immune system 
related organs; surface receptor on NK 
and some cytotoxic T-cells 
killer cell lectin-like receptor subfamily 
C, member 1 
Klrd1 
NK cell receptor; heterophilic cell 
adhesion; heavily localized in immune 
system organs 
killer cell lectin-like receptor, 
subfamily D, member 1 
Pim1 
cell growth/maintenance; localized in 
immune related organs/cells; effector of 
the IL-7 pathway  proviral integration site 1 
Dck 
nucleotide/nucleic acid metabolism; 
involved in lymphocyte response to DNA 
damaging angents deoxycytidine kinase 
Mgst3 
involved in the biotransformation of 
xenobiotics 
microsomal glutathione S-transferase 
3 
Bnip3l can interact with anti-apoptotic proteins 
BCL2/adenovirus E1B 19kDa-
interacting protein 3-like 
Psme3 
Implicated in immunoproteasome 
assembly and required for efficient 
antigen processing 
proteaseome (prosome, macropain) 28 
subunit, 3 
Prdx2 
may play an important role in 
metabolism; possibly involved in tumor 
necrosis peroxiredoxin 2 
Bcl2l negative regulation of apoptosis Bcl2-like 
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Icam4 
involved in red blood cell/immune cell 
interactions 
intercellular adhesion molecule 4, 
Landsteiner-Wiener blood group 
Lepr 
involved in fat metabolism; in a 
hematopoietic pathway required for 
normal lymphopoiesis leptin receptor 
Ceacam1 
involved in antigen:cell adhesion, 
angiogenesis, and tumorogenesis CEA-related cell adhesion molecule 1 
Ank1 involved in pathogen response ankyrin 1, erythroid 
Hmmr 
involved in cell motility and metastasis 
formation; localized in macrophage 
hyaluronan mediated motility receptor 
(RHAMM) 
Mki67 
involved in cell proliferation; regulation of 
cell cycle; highly localized in immune 
system organs 
antigen identified by monoclonal 
antibody Ki 67 
Spag5 
involved in cell cycle regulation; localized 
in immune system cells sperm associated antigen 5 
Papola 
involved in transcription and mRNA 
processing; localized in immune system 
cells poly (A) polymerase alpha 
Rtp801 involved in apoptosis HIF-1 responsive RTP801 
AI447904 
unknown function; highly localized in 
immune system related organs expressed sequence AI447904 
Csda 
binds to the Granulocyte/macrophate 
colony-stimulating factor (GM-CSF); 
possible repressor cold shock domain protein A 
Myd116 
stress response mediator; cell 
differentiation; localized in immune 
system related organs 
myeloid differentiation primary 
response gene 116 
Txnrd2 
electron transport; has role in cell 
survival & mitochondria-mediated 
apoptosis; localized in macrophage thioredoxin reductase 2 
Tal1 
DNA dependent transcription regulation; 
cell differentiation; hemopoiesis; located 
in immune system organs T-cell acute lymphocytic leukemia 1 
Igh-4 
antibacterial humoral response;antigen 
binding 
immunoglobulin heavy chain 4 (serum 
IgG1) 
Nfe2 
transcription regulation; DNA dependent 
and from Pol II promoter; hemostatis; 
localized in macrophage nuclear factor, erythroid derived 2 
Igk-V8 antigen binding 
immunoglobulin kappa chain variable 
8 (V8) 
Trim34 
function unknown; nearly entirely 
localized in immune system related 
organs tripartite motif protein 34 
Trim12 
function unknown; nearly entirely 
localized in immune system related 
organs tripartite motif protein 12 
A430056A10Rik 
function unknown; localized in immune 
system related organs RIKEN cDNA A430056A10Rik gene 
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5830484J08Rik 
involved in intracellular signaling 
cascade; highly localized in macrophage 
and lymph nodes RIKEN cDNA 5830484J08 gene 
A730011O11Rik 
involved in mitotic chromosome 
condensation; highly expressed in 
immune system related organs RIKEN cDNA A730011O11 gene 
2310046K10Rik 
function unknown; heavily localized in 
immune system RIKEN cDNA 2310046K10 gene 
2410018C20Rik Eukaryotic translation initiation factor RIKEN cDNA 2410018C20 gene  
9030611N15Rik involved in oxioreductase activity RIKEN cDNA 9030611n15 gene  
2810417H13Rik Unknown RIKEN cDNA 2810417H13 gene 
1300002F13Rik Unknown RIKEN cDNA 1300002F13 gene 
2810031L11Rik involved in lipid metabolism RIKEN cDNA 2810031L11 gene 
4432417N03Rik Unknown RIKEN cDNA 4432417N03 gene 
2010022I20Rik Unknown RIKEN cDNA 2010011l20 gene 
9530046H09Rik Unknown RIKEN cDNA 9530046H09 
1200014K04Rik Unknown RIKEN cDNA 1200014K04 gene 
1300010A20Rik Unknown RIKEN cDNA 1300010A20 gene 
1110063F24Rik Unknown RIKEN cDNA 1110063F24 gene 
2610005B21Rik expressed in proliferating cells in cycle RIKEN cDNA 2610005B21 gene 
1110063G11Rik highly expressed in the spleen RIKEN cDNA 1110063G11 gene 
4921526G09Rik Unknown RIKEN cDNA 4921526G09 gene 
0610041L09Rik Unknown RIKEN cDNA 0610041L09 gene 
2900037I21Rik involved in cytokinesis RIKEN cDNA 2900037I21 gene 
5730593F17Rik 
function unknown; localized in immune 
system related organs RIKEN cDNA 5730593F17 gene 
B230113M03Rik involved in the ubiquitin cycle RIKEN cDNA B230113M03 gene 
3010033P07Rik protein biosynthesis RIKEN cDNA 3010033P07 gene 
2810047L02Rik Unknown RIKEN cDNA 2810047L02 gene 
C920005C14Rik Unknown RIKEN cDNA C920005C14 gene 
1500001L20Rik 
localized in immune system related 
organs/cells RIKEN cDNA 1500001L20 gene 
2810027O19Rik Unknown RIKEN cDNA 2810027O19 gene 
0610016J10Rik Unknown RIKEN cDNA 0610016J10 gene 
2810433K01Rik Unknown RIKEN cDNA 2810433K01 gene 
1810013B01Rik Unknown RIKEN cDNA 1810013B01 gene 
1110005A03Rik Unknown RIKEN cDNA 1110005A03 gene 
2810453I06Rik Unknown RIKEN cDNA 2810453I06 gene 
2410005L11Rik Unknown RIKEN cDNA 2410005L11 gene 
5730469M10Rik Unknown RIKEN cDNA 5730469M10 gene 
1810015H18Rik Unknown RIKEN cDNA 1810015H18 gene 
B130022C14Rik Unknown RIKEN cDNA B130022C14 gene 
Trim30 
DNA-dependent transcription regulation; 
heavily localized in imune system related 
organs tripartite motif protein 30 
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Trim10 
plays a role in terminal differentiation of 
erythroid cells tripartite motif protein 10 
Xpo7 
Nuclear transport receptor; strongly 
expressed in bone marrow Exportin 7 
AI415282 
related to immunoreactivity in seizure-
sensitive/seizure-resistant animals pyridoxine-5'-phosphate oxidase 
Slc16a1 
membrane transporter-transports 
monocarboxylates; found in tumor cells monocarboxylic acid transporters 
Np95 (akaUhrf1) 
DNA binding transporter found in nucleus; 
related to cell proliferation & transcription 
regulation 
ubiquitin-like containing PHD & RING 
finger 
Rrm1 first step of dna replication pathway ribonucleotide reductase M1 
Rrm2 first step of dna replication pathway ribonucleotide reductase M2 
Mgst1 
enzyme which breaks down toxic solvents; 
found primarily in liver microsomal glutathione S-transeferase 1 
Gstm5 
enzyme which breaks down toxic solvents; 
found primarily in liver glutathione S-transferase, mu 5 
Pigq 
Functions in cytokinesis/cell viability through 
regulation of cell wall integrity phosphatidylinositol glycan, class Q 
Carhsp1 
DNA dependent; transcription regulation; 
found in bone marrow cells calcium regulated heat stable protein 1 
Nsg2 
Related to control of osteoblast 
differentiation; possibly related to golgi Neuron specific gene family member 2 
Rps6 selective translation of mRNA Ribosomal protein S6 
Hmgb3 
important extracellular mediator in local and 
systemic inflammation High mobility group box 3 
Aqp1 
water channel protein; maintains cellular 
osmotic environment; important in 
pathological process aquaporin 1 
Cedkn2d 
DNA dependent; transcription regulation; cell 
cycle regulation 
cyclin-dependent kinase inhibitor 2D 
(p19, inhibits CDK4) 
Abcb10 
ABC transporter involved in multi-drug 
resistance; localized to mitochonadrial inner-
membrane 
ATP-binding cassette, sub-family B 
(MDR/TAP) member 10 
Abcg2 
ABC transporter involved in multi-drug 
resistance 
ATP-binding cassette, sub-family G  
(WHITE) member 2 
Dctn6 involved in mitosis dynactin 6 
Cdc25b 
protein phosphatase required for progression 
of cell cycle (mitosis) 
cell division cycle 25 homolog B (S. 
cerevisiae) 
Cdc2a 
involved in cytokinesis and mitosis; localized 
in immune system related organs 
cell division cycle 2 homolog A (S. 
pombe) 
Rhced erythrocyte membrane transport protein Rhesus blood group CE and D 
Rhag 
membrane transport protein; involved in 
proteolysis and peptidolysis 
Rhesus blood group-associated A 
glycoprotein 
Ubce8 Ubiquitin conjugating enzyme activity ubiquitin-conjugating enzyme E2L 6 
Urod 
responsible for the fifth step in heme 
production   
Hmbs involved in third step of heme production hydroxymethylbilane synthase 
Uros 
responsible for the fourth step in heme 
production uroporphyrinogen III synthase 
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Fech 
produces last enzyme (8th) in heme 
production  ferrochelatase 
Wdr12 
related to the modulation of cell to cell 
communication WD repeat domain 12 
Lynx1 
neuronal membrane molecule which 
associates w/ nicotinic acetylcholine 
receptors in the CNS Ly6/neurotoxin 1 
Epb4.2 
regulates erythrocyte shape and mechanical 
properties Erythrocyte protein band 4.2 
Epb7.2 membrane transport protein erythrocyte protein band 7.2 
Asc 
promotes caspase-mediated apoptosis; 
located in cytoplasm 
apoptosis-associated speck-like protein 
containing a CARD 
Cdr2 mitosis-regulatory kinase cerebellar degeration-related 2 
Fbxo9 
involved in protein degradation pathway via 
ubiquitination f-box only protein 9 
Smc6l1 
involved in muscle contraction; found in thick 
filaments of the myofibrils 
SMC6 structural maintenance of 
chromosomes 6-like 1 
Mscp 
calcium-dependent mitochondrial solute 
carrier mitochondrial solute carrier protein 
Ccna2 involved in control of cell cycle (mitosis) Cyclin A2 
Rad51ap1 involved in DNA repair and recombination RAD51 associated protein 1 
Epim involved in epithelial morphogenesis epimorphin 
Hebp1 involved in heme metabolism heme binding protein 1 
Hemgn 
involved in the development of red blood 
cells hemogen 
Padi2 
catalyzes the post-transitional modification of 
proteins peptidyl arginine deiminase, type II 
Mkrn1 encodes zinc finger protein  makorin, ring finger protein, 1 
Dnaja4 
involved in stress response and protein 
chaperone activity in mitochondria 
DnaJ (Hsp40) homolog, subfamily A, 
member 4 
Dnajb10 
chaperone activity; heat shock protein 
activity; protein folding 
DnaJ (Hsp40) homolog, subfamily B, 
member 10 
Star 
involved in steroid biosynthesis and lipid 
transport steroiogenic acute regulatory protein 
Ermap 
adhesion/receptor molecule specific for 
erythroid cells 
erythroblast membrane associated 
protein 
Cyp4f18 nucleic acid binding and electron transport 
cytochrome P450 family 4, subfamily f, 
polypeptide 18 
Ect2 
involved in cell growth, regualation of the cell 
cycle ect2 oncogene 
Supt16h helps uncoil DNA during transcription 
suppressor of Ty 16 homolog (S. 
cerevisiae) 
Ccnb1 Regulation of the cell cycle (mitosis) Cyclin B1 
D15Ertd417e 
maintains trancriptionally recepressive state 
of gene; involved in chromatin modification 
DNA segment, Chr15, ERATO Doi 417, 
expressed 
D9Bwg0185e 
intracellular protein transport; small GTPase 
mediated signal transduction 
DNA segment, Chr 9, Brigham & 
Women's Genetics 0185 expressed 
Eif2s1 
translation initiation factor; involved in protein 
biosynthesis 
eukaryotic translation initiation factor 2, 
subunit 1 alpha 
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Eif2ak1 
regulation of translation, negative regulation 
of protein biosynthesis 
eukaryotic translation initiation factor 2 
alpha kinase 1 
Gch 
rate-limiting enzyme in production of 
tetrahydrobiopterin GTP cyclohydrolase 1 
Cpeb4 
possibly involved in the temporal activation 
of mRNA, controls translation 
cytoplasmic polyadenylation element 
binding protein 4 
Fgf10 
involved in the morphogenesis of several 
tissus by control of mesenchymal-to-
epithelial signaling fibroblast growth factor 10 
Ccndbp1 involved in protein binding cyclin D-type binding-protein 1 
Vig1 Unknown 
viral hemorrhagic septicemia virus 
(VHSV) induced gene 1 
Rpgrip1 
involved in eye photoreceptor cell 
development 
retinitis pigmentosa GTPase regulator 
interacting protein 1 
Butr1 
belongs to the immunoglobulin superfamily; 
may function in secretion of milk-fat droplets Butyrophilin related 1 
Rnpc1 Unknown RNA-binding region  
Spna1 
essential component of the red blood cell 
cytoskeleton spectrin alpha 1 
Hipk1 
co-repressor for homeodomain transcription 
factors; may play role in tumorigenesis 
homeodomain interacting protein kinase 
1 
Ccne2 Cell cycle control; DNA replication inititation Cyclin E2 
Slc7a2 amino acid transporter 
solute carrier family 7 (cationic amino 
transporter, y+ system), member 2 
Calmbp1 Unknown calmodulin binding protein 1 
Gda critical in nucleotide metabolism guanine deaminase 
Trfr involved with iron ion homeostasis Transferring receptor 
Gypa 
regulation of erythrocyte response to osmotic 
stress; cytoskeletal anchoring glycophorin A 
Rnf10 Unknown ring finger protein 10 
Rnf11 ubiquitin –dependent protein catabolism ring finger protein 11 
Sgne1 
involved in neuropeptide signaling pathway; 
may regulate hormone secretion 
secretory granule neuroendocrine protein 
1, 7B2 protein 
Cnnm2 Unknown Cyclin M2 
Metap2 
involved in regulation of protein 
synthesis/modification; localized in 
macrophage and bone marrow methionine aminopeptidase 2 
Prc1 
integral component of centrosome; used 
during cytokinesis; localized in macrophage 
and spleen protein regulator of cytokinesis 1 
AW146242 Unknown expressed sequence AW146242 
AW1088241 Unknown expressed sequence AW1088241 
Smap1 
positive regulation of erythrocyte 
differentiation stromal membrane-associated protein 1 
Bub1 
modulates time of anaphase initiation 
(mitosis); involved in chromosome 
segregation and tumor metastasis 
budding uninhibited by benzimidazoles 1 
homolog (S. cerevisiae) 
BC034753 
DNA repair; localized in immune system 
organs cDNA sequence BC034753 
 71 
Dyrk3 
Involved in cellular growth and/or 
development 
dual-specificity tyrosine-(Y)-
phosphorylation regulated kinase 3 
Smox 
involved in electron transport and spermine 
catabolism spermine oxidase 
Birc5 
may counteract a default induction of 
apoptosis in g2/m phase baculoviral IAP repeat-containing 5 
Rfc4 DNA replication/strand elongation replication factor C (activator 1) 4 
Tm4sf3 
involved in pathogenesis, signal transductor 
activity; intraheptic heptacellular carcinoma transmembrane 4 superfamily member 3 
Pins (aka 
Gpsm2) involved in signal transduction pins homolog (Drosophia) 
Ube4a involved in ubiquitin cycle 
ubiquitination factor E4A, UFD2 homolog 
(S. cerevisiae) 
BC022224 Unknown cDNA sequence BC022224 
Hspb1 
involved in heat stress resistance and actin 
formation heat shock protein 1 
Cmas involved in lipopolysaccharide biosynthesis 
cytidine monophospho-N-
acetylneuraminic acid synthetase 
Map4k5 
serine/threonine protein kinase required for 
spore wall development 
mitogen-activated protein kinase kinase 
kinase kinase 5 
Lek1 has a role in mitosis and cell development 
leucine, glutamic acid, lysine family 1 
protein 
Sox6 
cell differentiation; DNA dependent 
transcription regulation SRY-box containing gene 6 
Nudt7 
regulation of CoA and Acyl-CoA in response 
to metabolic demand 
nudix (nucleoside diphosphate linked 
moiety X)-type motif 7 
Arl4 
used in signal transduction and protein 
transport ADP-ribosylation factor-like 4 
Nnmt involved in papillary carcinomas nicotinamide N-methyltransferase 
Ptdss2 phosphatidylserine biosynthesis phosphatidylserine synthase 2 
Ptp4a2 
protein amino acid dephosphorylation; 
localized in immune system related organs protein tyrosine phosphatase 4a2 
Cd24a involved in cell differentiation CD24a antigen 
Hagh hydroxyacylgltathione hydrolase activity hydroxyacyl glutathione hydrolase 
Kif2c 
microtubulal based processes during cell 
cycle and meiosis kinesin family member 2C 
6330505N24 Unknown hypothetical protein 6330505N24 
Al506816 Unknown expressed sequence AI506816 
Smc2l1 
involved in mitosis; transport; and 
chromosome organization and biogenesis 
SMC2 structural maintenance of 
chromosomes 2-like 1 (yeast) 
Car2 one carbon compound metabolism carbonic anhydrase 2 
Atpi negative regulation of nucleoside metabolism ATPase inhibitor 
Gpx3 cellular response to oxidative stress glutathione peroxidase 3 
Fech 
produces last enzyme (8th) in heme 
production  ferrochelatase 
Siat9 protein amino acid glycosylation 
sialyltransferase 9 (CMP-
NeuAc:lactosylceramide alpha-2,3-
sialyltransferase) 
 72 
Gadd45a 
regulation of cell cycle (cell cycle arrest); 
response to DNA damage stimulus; protein 
biosynthesis 
growth arrest and DNA-damage-inducible 
45 alpha 
Adk 
involved in purine metabolism; regulator of 
adenosine adenosine kinase 
Ncoa4 
Binds&activates androgen receptor (AR) in 
ligand-dependent manner; involved in 
transcription & cell growth/maintenance nuclear receptor coactivator 4 
Mxi1 transcriptional repressor; involved in cancer Max interacting protein 1 
Ank skeletal development; phosphate transport Progressive ankylosis 
Cenpa chromosome organization and biogenesis centromere autoantigen A 
Mpp1 
involved in coupling the cytoskeleton to the 
cell membrane; cell growth/proliferation membrane protein, palmitoylated 
Xdh 
involved in electron transport; regulation of 
epithelial cell differentiation, and lactation xanthine dehydrogenase 
Ifrd2 cell differentiation/proliferation 
interferon-related developmental 
regulator 2 
Nt5c3 
regulation of transcription; localized in 
immune system related organs 5'-nucleotidase, cytosolic III 
Dapk2 positive regulation of apoptosis death-associated kinase 2 
Sc5d metabolism; sterol biosynthesis 
sterol-C5-desaturase (fungal ERG3, 
delta-5-desaturase) homolog (S. 
cerevisae) 
Hop involved in cardiogenesis Homeodomain only protein 
Add2 
membrane ion transport; hemopoiesis; blood 
pressure regulation adducin 2 (beta) 
Cul4a negative regulator of cell cycle; oncogenesis Cullin 4A 
BC025474 Unknown cDNA sequence BC025474 
Kif11 
microtubule-based process (centrosome 
separation); localized in immune system 
related organs kinesin family member 11 
Sfrs2 nuclear mRNA splicing via spliceosome 
splicing factor, arginine/serine-rich 2 (SC-
35) 
Ube2c 
ubiquitin cycle; positive regulation of cell 
proliferation; cytokinesis; localized in immune 
system ubiquitin-conjugating enzyme E2C 
Rpl17 
Positive regulation of I-kappaB kinase/NF-
kappaB cascade ribosomal protein L17 
Gnb1 
phototransduction; acetyl choline receptor 
signaling; RAS protein signal transduction 
guanine nucleotide binding protein, beta 
1 
D130005A03 Unknown hypothetical protein D130005A03 
Epb4.9 
cellular morphogenesis; cytoskeleton 
organization and biogenesis erythrocyte protein band 4.9 
 
